Ohio 2013 CollAboRAti E LAboRAtoR CoNFERENcE

Transcription

Ohio 2013 CollAboRAti E LAboRAtoR CoNFERENcE



Ohio 2012
Collaborative Laboratory
Conference
April 25 – 27, 2012
Crowne Plaza North

h

Col
umbu
s,O
io
2011 CLC Organization

 Logos


2011 CLC Organization Logos

The
The Clinical
Clinical Laboratory
Laboratory Conference
Conference Steering
Steering Committee,
Committee, Program
Program Committees,
Committees, AACC-NE
AACC-NE Ohio
Ohio
Section,
ASCLS-Ohio
and
CLMA-First
Ohio,
Six
Rivers
and
Western
Lake
Erie
Chapters
Section, ASCLS-Ohio and CLMA-First Ohio, Six Rivers and Western Lake Erie Chapters are
are pleased
pleased
to extend an invitation to YOU to attend “Ohio CLC 2013: An Exploration of Medical Laboratory
to extend an invitation to YOU to attend “Ohio CLC 2013: An Exploration of Medical Laboratory
Science." Because the quality of your continuing education can directly affect your professional
Science." Because the quality of your continuing education can directly affect your professional
development and achievements, this educational conference is designed by YOU for YOU, the clinical
development and achievements, this educational conference is designed by YOU for YOU, the clinical
laboratory professional.
laboratory professional.
Who Should Attend:
All clinical laboratory practitioners, educators, students, supervisors,
Who Should Attend:
All
clinical laboratory
educators, students, supervisors,
managers,
directors, practitioners,
and phlebotomists.
managers, directors, and phlebotomists.
Benefits of Attending:
 Review current technologies and learn new techniques
Benefits of Attending:

current
and learn new techniques
 Review
Formulate
ideastechnologies
for further development

Formulate
ideas
for
further
development
 Gain insights into future laboratory practice

insights
into future
laboratory
practice
 Gain
Network
with your
professional
colleagues

Network
with
your
professional
colleagues
 Enhance your career potential
Enhance
your career
potential
 Relax
. . Learn
. . Share
. . Have Fun!
 Relax . . Learn . . Share . . Have Fun!
Full Registration:
Registration Includes:
Full Registration:
Registration Includes:
 Attendance at all conference sessions
Attendance
at all conference
sessions
 Lunch
plus morning
and afternoon
refreshment breaks
 Wednesday
eveningand
dinner
Lunch plus morning
afternoon refreshment breaks
Daily Registration:
 Wednesday evening dinner
 All sessions, refreshment breaks and lunch either day
Daily Registration:
 All sessions, refreshment breaks and lunch either day
CLC Steering Committee
CLC Steering
Committee
Dustin
Bunch, Co-Chair
Dustin
MelanieBunch,
Giusti,Co-Chair
Co-Chair
Melanie Giusti,
Co-Chair
Catherine
Shaffner,
Treasurer
Catherine
Pam
Kin Shaffner, Treasurer
Facilities/Social/Hospitality Committee
Facilities/Social/Hospitality
Committee
Laura
Hook, Chair
Laura
Hook, Chair
Kay Hanna
Kay Hanna
Shannon
Kern
Shannon Kern
Pam
Allen Kin
Nickels
Promotion & Publicity Committee
Pam Kin, Chair
Promotion
& Publicity Committee
Allen
StacyNickels
Baker
Jane
Tester
Stacy Baker
Eugenio
Zabaleta, PhD
Jane
Tester
Eugenio Zabaleta, PhD
Program Committee
Joe El-Khoury,
PhD, Chair
Program
Committee
Stacy
Baker (PACE)
Joe El-Khoury,
PhD, Chair
Melanie
Giusti
Stacy Baker (PACE)
Linda Graeter
Melanie Giusti
Rhonda Perry
Linda Graeter
Christine Schmotzer, MD
Rhonda Perry
Eugenio
PhD
ChristineZabaleta,
Schmotzer,
MD
Greg
Attenweiler
Pam Kin,
Chair
DustinAttenweiler
Bunch (Cvent)
Greg
Dustin Bunch (Cvent)
Registration Committee
Rosanne Kelley, Chair
Registration Committee
Lisa
KubitKelley,
(Cvent)Chair
Rosanne
Jane
Tester
Lisa Kubit
(Cvent)
Jane Tester
Vendors/Exhibit Committee
Allen Nickels, Chair
Vendors/Exhibit Committee
Paul Labbe
Allen Nickels, Chair
Paul Labbe
Eugenio Zabaleta, PhD

2





This year’s keynote speaker is Nancy Riesz, MBA,
MT(ASCP), ACC. She is President of Success
Catalyst, a certified Woman Business Enterprise,
which she founded in 1993. She has been teaching
people how to better work together for 35+ years. 
This interactive session shares specific skills and provides solutions for working
better…. together. In today’s world of rapid technological and social change, teamwork
is not a luxury. It is a necessity. Yet, establishing teamwork in the laboratory is not
always easy. It requires commitment, cooperation and effort, as well as a willingness to
accept and appreciate the uniqueness of others. This presentation will explore ways to
develop effective teams at work, to build team unity and strengthen team spirit and
ultimately to work together…better with teammates.

During the conference, you will have a great opportunity to enhance your learning
experience by “Visiting the Vendors” to see and hear about all the newest laboratory
instrumentation and testing products.
Thursday, May 9
12:00 pm – 5:00 pm
Vendor Reception
5:00 pm – 7:00 pm
Friday, May 10
9:30 am – 1:30 pm
At various times during vendor exhibit hours, there will be door prize drawings – but you
must be present to win.
Be sure to include some time to visit with our vendors / sponsors during the conference.
The CLC organizations are extremely grateful for the generosity from our laboratory
industry vendor friends that allow us to provide affordable continuing education to
Ohio’s laboratory professionals. A complete listing of vendor exhibitors and sponsors
will be provided to all conference attendees.
3
Program
Glance
Program at
at a Glance
OHIO
OHIO2013
2013COLLABORATIVE
COLLABORATIVE LABORATORY
LABORATORY CONFERENCE
CONFERENCE
An
AnExploration
Explorationof
ofMedical
Medical Laboratory
Laboratory Science
Science
May
May88 –– May
May 10, 2013
2013
Wednesday,
Wednesday,
May
May
8 8
12:30
– 5:00
12:30
– 5:00
Registration
Registration
W1
W1
Point
of of
Care
Testing
Point
Care
Testing
1:001:00
– 2:00
– 2:00
W2
Mass
Automationinin
MassSpec
Spec and Automation
MICRO,
to be
bekidding!
kidding!
MICRO,you’ve
you’ve got to
W3
W3
Quality
Planning
with
CMS’
Quality
Planning
with
CMS’
Individualized
Plan
Individualized
QCQC
Plan
Katharine
MT(ASCP),SM,
SM,
Katharine Roman,
Roman, MT(ASCP),
CIC(CBIC)
CIC(CBIC)
SharonEhrmeyer,
Ehrmeyer,
PhD,
(ASCP)
Sharon
PhD,
MTMT
(ASCP)
Edmunds
Z. Z.
Reineks,
MD,PhD
Edmunds
Reineks,
MD,PhD
Sponsored
Abbott
Sponsored
by by
Abbott
2:002:00
– 2:30
– 2:30
2:302:30
– 3:30
– 3:30
Refreshment
Break
Refreshment Break
W4
W4
The
Power
ofof
“Like”:
The
Power
“Like”:Social
Social
Media
Marketing
AsAs
AA
Tool
Media
Marketing
ToolFor
For
Laboratory
Business
Expansion
Laboratory
Business
Expansion
Scottia
E. E.
Miller,
MT
(ASCP)
Scottia
Miller,
MT
(ASCP)
– 4:45
3:453:45
– 4:45
W7
W7
Laboratory
Competency
Laboratory
Competency
W5
High
Testingin
inthe
the
HighStakes
Stakes Drug Testing
Neonate
Neonate
Steven
PhD,
Steven W.
W. Cotten,
Cotten, PhD,
DABCC,
NRCC
DABCC, NRCC
W8
Howdo
do we
we get Physicians
How
Physiciansto
to
Order the
the Right
Right Test?
Order
Test?
Ruth
Natali,
(ASCP),SH
Ruth
Natali,
MTMT
(ASCP),SH
W6
W6
Evaluation
AIDS
Gene
Therapy
Evaluation
ofof
AIDS
Gene
Therapy
strategies
a group
of High
strategies
byby
a group
of High
Schooland
and
Community
College
School
Community
College
Students
a Science
enrichment
Students
inin
a Science
enrichment
program
program
Harry
Kestler,
PhD
Harry
Kestler,
PhD
W9
W9
Where
the
data
lives:
Data
Where
the
data
lives:
Data
Warehousing,
Virtualization
andand
Warehousing,
Virtualization
“cloud”
in in
thethe
modern
LabLab
“cloud”services
services
modern
Eugenio Zabaleta,
Zabaleta, PhD
Eugenio
PhD
Arkadiy
Kheyfets,
MS.Eng,
PMP,
Arkadiy
Kheyfets,
MS.Eng,
PMP,
CISSP,
CCDA
CISSP,
CCDA
– 7:00
5:005:00
– 7:00
Dinner
Dinner
– 9:00
7:007:00
– 9:00
ASCLS-OH Board
Board of Directors
ASCLS-OH
DirectorsMeeting
Meeting
4
Program-at-a-Glance
Thursday,
May912
Thursday, May
8:00-5:30
8:00
– 5:00
Registration
Registration
8:00-9:00
8:00
– 8:30
Continental
Breakfast
Continental Breakfast
T11T11
T10T10
Managing
PreanalyticalHemoglobin
A History
of the
A1c for
the
Lean Six Sigma:
Variables
During
Shortages:
2000-2050
Eliminating the 3 D’s (Delay,
diagnosis of diabetes
Venipuncture
Collection
Defects,
and Deviation)
to
8:30 – 9:30
9:00-10:00
Thomas Williams, MD
Produce Better, Faster,
Sihe
Wang, PhD,
More
Profitable
Results
Lorraine
Tyndell,
MS, MT
DABCC, FACB
(ASCP)
Denise M. O’Conner,
Sponsored
MT(ASCP) by BD
Sponsored by Siemens
T13
T13
T12T12
of Lab
Infection
CSI/Reality
Effective
Educational
IsThe
the State
Current
Immunology:
Case
Modalities
in Clinical
Allied
BusinessControl
Model at a
Studies of Problem
Health Education
Strategic Inflection
Resolution for
Amy Ray, MD,MPH
Point?
Infections Disease &
Craig Clifford, MD, MS
Autoantibody Testing
Khosrow Shotorbani, MBA,
MT(ASCP)
Thomas Alexander,
Sponsored by ARUP
PhD, D(ABMLI)
Laboratories
10:00-10:30
Refreshment Break/Visit Vendors
10:30-11:30
Welcome & Keynote Address T14 “Collaboration Celebration”
9:30 – 9:45
Refreshment Break
Welcome & Keynote Address T14: Working Together: Moving from Me to We
T15
T16
T17
T18
Nancy J. Riesz,
MT(ASCP),
ACC
Surviving Sepsis
Preventing
and MBA,Using
Gel Automation
in
Blood Lead Testing
T182010
T15
T16 Violence
Controlling
theT17
Blood Bank
After
Recurrent infections in
Pediatric Blood Sparing:
whatMA,
is this
101
11:45:12:45 No, really,
in Screening
the Workplace
John Ancy,
RRT Prenatal
AnNeil
interdisciplinary
anAndrea
Adult or
a Kid?MLS
patient’s blood type?!
Hickey,
Conway, quality
PhD,
11:00 –12:00
improvement initiative
to standardize
Christine
Wensel,
MS,MS
Cindy
Zastrow,
DABCC
Sponsored by
It might be a PID! Clinical
and minimize blood sampling
and Laboratory Update on
Suzanne
Bakdash, MD,
CGC
Instrumentation
volumes
and reduce pre-analytical
Primary Immune Deficiencies
Laboratory
MPH
testing errors
9:45 – 10:45
12:45-2:00
12:00 – 1:30
2:00-3:00
1:30 – 2:30
3:00-3:30
3:30-4:30
2:45 – 3:45
3:45 - 4:00
4:45-5:45
4:00 – 5:00
6:00-8:00
5:00 – 7:00
Lunch/Visit
Vendors
Thomas
S. Alexander,
Paula L. Forsythe, MSN, RN,
PhD, D(ABMLI)
T19
T20
T21
T22
CNS
Laboratory Diagnosis of Laboratory Safety: It’s
Cancer Stem Cells:
Case Studies in
Luncheon
Bacteremia and
not Just for
the Rats & Visit Vendors
Implications for
Clinical Microbiology
Fungemia Including
Anymore
Diagnosis, Prognosis
T22
T20
T21
RapidT19
Identification
and
Treatment
Chuck
Sylvain,
Moving
on
Up!
Fast Track &
You
Say
Apple,
I
say
Leadership
in
an
Health
Care
Reform
Techniques
Cindy Zastrow, MS
M(ASCP)
Career
Paths
for
Orange, An Attempt to
emerging healthcare
Status
Report
–
3
years
J.Lynne Williams, PhD,
Phlebotomists
Standardize the Grading since PPACA MLS
organization
signed into
Gerri Hall, PhD
Jake Orville
of Hematology
Morphology
law
Elaine Ewald & Terrie
McManes
Sponsored by CompuNet
Clinical
Catherine Shaffner,
T23
T24
T25
T26
Laboratories
MLS(ASCP)SH
Job Selection Criteria
HCG Testing:
Epigenetics-It’s not so
Automating the Urine
T25 After All
T24
T26
T23Influence of
and the
Challenges
and
Scary
Testing
Workflow
Clinical
Laboratory Pediatric Phlebotomy
Pitfalls
Are These Lab Values
A tale of two algorithms:
How
Reproductive
Rotations
J.Lynne Evaluating
Williams, PhD, Laboratory
Kevin
Barta, BSof HIV
Accurate?
diagnosis
Laboratories
Differ
MLS with
Laboratory Results
and Treponema pallidum
from Clinical
RandyChristine
Gruhlke Schmotzer,
BS, CPT,
J.Michele
Stuart, PhD,
MD
Sponsored
Specimen Quality
infection.by Iris
Laboratories
(NHA)
CM
MLS (ASCP)
Diagnostics
T28Medical
T29 MS,
Sponsored by Mayo
Doris J. Baker,T27
PhD, MT
Sandra VanVranken,
Mario
J Marcon,PhD,
Organization
Business
Using HCLD
Patient’s
DNA to
Clinical
Presentation
Is
Cervical Cancer a
Laboratories
(ASCP),
(ABB),
MT(ASCP)SH
D(ABMM)
Meeting(s) CLMA
Prescribe Clopidogrel
and Diagnosis of
Preventable Disease?Emb-Acad.
(ACE)
(Plavix)
Hypercoagulable
The role of HPV
Refreshment Break/Visit Vendors
Conditions
Screening
Eugenio
Zabaleta, PhD
T27
IrinaT28
Chibisov, MD
BelindaT29
Yen-Lieberman,
Critical Values: Cutoffs, Laboratory
What Next? I want or
Monitoring
PhD,
SV(ASCP)of
Organization Business
Communication,
and for
need a new job!
Heparin Therapy
Sponsored by Institute
Meeting (CLMA)
Impact
on Care
Transfusion
Medicine
James A. Rowe, MBA,
Kathy Shingler, MT(ASCP)
by Instrumentation
HT, MT (ASCP),FACHE
VendorSponsored
Reception
Christine Schmotzer,MD
Refreshment Break/Visit
Vendors Paul Labbe,
MCLT
Laboratory
Vendor Reception
5 5
Program-at-a-Glance
Thursday,
May
Friday, May
10 12
8:00-5:30
7:30
– 3:30
Registration
Registration
8:00-9:00
7:30
– 8:30
Continental
Breakfast
ASCLS-OH
Member Business
Meeting
8:00 – 8:30
9:00-10:00
8:30 – 9:30
10:00-10:30
9:30 – 10:00
10:30-11:30
T10
Managing Preanalytical
Variables During
F30 Collection
Venipuncture
T11
T12
Continental
A History
of the Breakfast/Networking
The State of Infection
Shortages: 2000-2050
Control
F31
F32
Reviewing and
Rapid
Identification
Metabolic
Acidosis
&
Thomas
Williams,ofMD
Amy Ray,
MD,MPH
Revising
Reference
Blood
Culture
Isolates
Metabolic
Alkalosis
Lorraine Tyndell, MS, MT
Intervals: Challenges
(ASCP)
and Options
Ike Northern, MT,
Michael D. Patterson, DO
Sponsored by BD
M(ASCP), MS
Amy L. Pyle, PhD,
DABCC
Refreshment Break/Visit Vendors
T13
CSI/Reality
Immunology: Case
StudiesF33
of Problem
Clotting
or Bleeding?
Resolution
for A
Case
Study-Based
Review
Infections Disease
&
of Hemostasis
Autoantibody
Testing
Thomas
Alexander,
Charity
Accurso,
PhD
PhD,
D(ABMLI)
MT(ASCP)
Refreshment Break/Visit Vendors
Welcome & Keynote Address T14 “Collaboration Celebration”
F37
F35
F36
F34
T15 of
T16 Test Trauma Packs
T17
T18
Blood Gases
– Let’s Get
Controlling Genetic
& Massive
ASCP Board
Surviving Sepsis
Preventing and
Using Gel Automation in
Blood Lead Testing
Clinical
Send Out Volume
Transfusions, What to
Certification
Controlling Violence
the Blood Bank
After 2010
Do?
Examinations
and
11:45:12:45
in the Workplace
John Ancy, MA, RRT
10:00
–11:00
Certification
Erik
Gallion,
RCP/RRT
Patty Taneja, M.S, CGC
Andrea Hickey, MLS
Neil
Conway,
PhD,
Maintenance
Program
Suzanne
H.
Butch,
MA,
Cindy Zastrow, MS
DABCC
Sponsored by
CM
CM
MLS(ASCP) SBB
Instrumentation
Susan L. Wilkinson,
LaboratoryEdD,
CM
MT(ASCP)SBB
12:45-2:00
F38
F39 Lunch/Visit Vendors
F40
F41
Drug Screening
Molecular Genetics
of
T19 for
Develop a Business
Case
T20
T21
A review ofT22
antimicrobial
Laboratory
Laboratory Safety: It’s
Cancer
Stem
Cells:
Case Studies
in
Pain Diagnosis of Myeloproliferative
That
Will Get
Your
susceptibility
testing
Bacteremia and
not Just forand
the Rats
Implications
Clinical
Microbiology
Management
Neoplasms
Initiative
Fundedfor
methods
11:15 –12:15
Fungemia Including Myelodysplastic
Anymore
Diagnosis, Prognosis
– New
2:00-3:00
Rapid
Identification
andStegall,
Treatment
Chuck Sylvain,
Discoveries Explain Old
Binit
J. Shah,
MD
M. Susan
MBA,
Joel Mortensen,
MLT (AMT),
Techniques
Cindy
Zastrow,
MS
M(ASCP)
Observations
MHSA, MT(ASCP)
PhD
J.Lynne Williams, PhD,
Sponsored by Meridian
J. Lynne Williams, PhD,
Gerri Hall, PhD
MLS
Bioscience
MLS
12:15
– 1:30
3:00-3:30
3:30-4:30
1:30 – 2:30
F42T23
Laboratories
Job Selectionin
Criteria
Developing
and the Countries:
Influence of
Clinical
Laboratory
A
Cambodian
Rotations
Experience
Stuart,
PhD,
B.J.Michele
Laurel Elder,
PhD
CM
2:30 – 2:45
4:45-5:45
2:45 – 3:45
6:00-8:00
Lunch/Vendor
Exhibits
Refreshment
Break/Visit
Vendors F45
F43T24
F44
T25
T26
Leukemia
Casethe
Studies:
Vaccination
Is
Not
What
to
do
with
the
new
HCG Testing:
Epigenetics-It’s not so
Automating
Urine
the Good,
theWorkflow
Bad and the
Immunization
technology
andAll
Challenges and
Scary After
Testing
Pitfalls
Ugly
molecular methods in
J.Lynne
Williams, PhD,
Kevin Barta, BS
clinical
microbiology?!
Kathy V. Waller, PhD,
Christine
MLS MLT
Roslyn McQueen, PhD,
MLSSchmotzer,
Joel Mortensen,
MD
Sponsored
CCRC by Iris
(AMT), PhD
Diagnostics
Sponsored by Meridian
T28
T29
Bioscience
Organization Business
Clinical Presentation
Is Cervical Cancer a
Meeting(s) CLMA
Refreshment
Break
and Diagnosis
of
Preventable
Disease?Hypercoagulable
The role of HPV
F49
F46
F47
F48
Conditions
Screening
Blood Product utilization &
iPath touch: The Value
Project Management
Interferon
Gamma
Eugenio Zabaleta, PhD
IrinaEasy
Chibisov,
Belinda
Yen-Lieberman,
Wastage
of Touch Imprints in
Made
plus MD
Release
Assays
(IGRAs)
PhD,
SV(ASCP)
Pathology
Fundamentals
in the Diagnosis
of
Sponsored by Institute for
Tuberculosis
Bob Reigle, MLS (ASCP)
Transfusion
Samir B. Kahwash, MD
M. Susan
Stegall,Medicine
MBA,
Richard B. Clark, PhD,
MLS (ASCP)
T27
Using Patient’s DNA to
Prescribe Clopidogrel
(Plavix)
MHSA, MT(ASCP)
D(ABMM)
Vendor Reception
Sponsored by Quest
Diagnostics
2:30 – 5:00
6 Academic Challenge & Student Mixer
5 SessionAbstracts
Abstracts 2013
2013
Session
Session
Abstracts
2013
Please note that the “level of instruction” is designated as Basic (B), Intermediate (I)
Please
note
the
“level
instruction”
isisdesignated
Please
notethat
that
the
“levelof
of
instruction”
designatedas
asBasic
Basic(B),
(B),Intermediate
Intermediate(I)
(I)
or Advanced
(A)
following
the
title for each
session.
or
orAdvanced
Advanced(A)
(A)following
followingthe
thetitle
titlefor
foreach
eachsession.
session.
W1. Point Of Care Testing (B)
W1.
W1
W1.Point
PointOf
OfCare
CareTesting
Testing(B)
(B)
Edmunds Z. Reineks, MD, PhD
Edmunds
Z.Z.Reineks,
Edmunds
Reineks,
MD,
PhD
Medical Director
of Point ofMD,
CarePhD
Testing and Automated
Medical
Director
Medical
DirectorofofPoint
PointofofCare
CareTesting
Testingand
andAutomated
Automated
Chemistry
Chemistry
Chemistry
Cleveland Clinic
Cleveland
ClevelandClinic
Clinic
Several case studies in point of care testing will be
Several
case
point
testing
will
Several
case
studies inin
point ofof
care
testing
will
be
presented
to studies
illustrate
problems
orcare
issues
related
to be
this
presented
to
illustrate
problems
or
issues
related
to
this
presented
to
illustrate
problems
or
issues
related
to
this
type of testing.
type
typeofoftesting.
testing.
W2. Mass spec and automation in micro,
W2.
Mass
spec
and
automation
W2
W2.
Mass
spec
and
automation
micro,
you’ve
got
to be
kidding!
(I) ininmicro,
you’ve
you’vegot
gotto
tobe
bekidding!
kidding!(I)
(I)
Katharine Roman, MT(ASCP),SM, CIC(CBIC)
Katharine
Roman,
CIC(CBIC)
Katharine
Roman,MT(ASCP),SM,
MT(ASCP),SM,
CIC(CBIC)
Manager, Microbiology
Laboratory
Manager,
Microbiology
Laboratory
Manager,
Microbiology
Laboratory
University
Hospitals Case
Medical Center
University
UniversityHospitals
HospitalsCase
CaseMedical
MedicalCenter
Center
An overview of what MALDI-TOF is, how MALDI-TOF
An
overview
MALDI-TOF
is,is,how
An
overview
ofwhat
whatmicrobiology
MALDI-TOF
howMALDI-TOF
MALDI-TOF
fits
into our of
current
laboratory
workflow
and
fits
into
fits
intoour
ourcurrent
current
microbiologylaboratory
laboratoryworkflow
workflow
and
what
future
state microbiology
microbiology
laboratories
will lookand
like
what
state
laboratories
will
what
future
statemicrobiology
microbiology
laboratories
willlook
looklike
like
withfuture
MALDI-TOF
plus total lab
automation……...like
a
with
MALDI-TOF
with
MALDI-TOF
plustotal
totallab
labautomation……...like
automation……...likeaa
chemistry
lab???plus
chemistry
chemistrylab???
lab???
W3. Quality Planning with CMS’
W3
W3.
Quality
with
CMS’
W3.
QualityPlanning
Planning
with
CMS’
Individualized
QC Plan
(B)
Individualized
QC
Plan
(B)
Individualized QC Plan (B)
Sharon Ehrmeyer, PhD, MT (ASCP)
Sharon
Ehrmeyer,
PhD,
MT
Sharon
Ehrmeyer,
PhD,
MT(ASCP)
(ASCP)
Professor,
Pathology and
Laboratory
Medicine
Professor,
and
Professor,
Pathology
andLaboratory
Laboratory
Medicine
Director,Pathology
Clinical
Laboratory
ScienceMedicine
Director,
Clinical
Laboratory
Science
Director,
Clinical
Laboratory
Science
University of Wisconsin-Madison
University
UniversityofofWisconsin-Madison
Wisconsin-Madison
In March, 2012, CMS announced its new QC policy,
InInIndividualized
March,
CMS
itsits(IQCP),
new
policy,
March, 2012,
2012,Quality
CMS announced
announced
new QC
QC
policy,
Control
Plans
based
on
Individualized
Quality
Control
(IQCP),
based
on
Individualized
Quality
ControlPlans
Planswill
(IQCP),
based
on
risk management
concepts.
IQCP
replace
(2015?)
risk
(2015?)
risk
management
concepts.
IQCP
willreplace
replace
(2015?)
themanagement
current EQCconcepts.
policy forIQCP
sites will
using
manufacturers’
the
current
EQC
for
manufacturers’
the
current
EQC policy
policyAccording
for sites
sites using
manufacturers’
built-in
assessments.
tousing
CMS,
IQCP permits
built-in
assessments.
According
totoCMS,
permits
built-in
assessments.
According
CMS,IQCP
IQCP
permits
test sites
to customize
quality assessments
to their
test
test
sites
to
customize
quality
assessments
to
their
test
sites
to
customize
quality
assessments
to
their
test
systems and testing situations. This presentationtest
will
systems
testing
situations.
This
presentation
systems
and
testing
situations.
This
presentationwill
will
discussand
IQCP
and its
development
process.
discuss
discussIQCP
IQCPand
anditsitsdevelopment
developmentprocess.
process.
Sponsored by Abbott
Sponsored
Sponsoredby
byAbbott
Abbott
W4. The Power of “Like”: Social Media
W4.
The
of
“Like”:
W4
W4.
ThePower
Power
ofTool
“Like”:
SocialMedia
Media
Marketing
As A
ForSocial
Laboratory
Marketing
As
A
Tool
For
Laboratory
Marketing
As
A
Tool
For
Laboratory
Business Expansion (B)
Business
BusinessExpansion
Expansion(B)
(B)
Scottia E. Miller, MT (ASCP)
Scottia
E.
ScottiaTechnologist
E.Miller,
Miller,MT
(ASCP)
Medical
IIMT(ASCP)
Medical
Technologist
Medical
Technologist
The
Christ
Hospital IIII
The
TheChrist
ChristHospital
Hospital
As the relatively new idea of social media begins to
As
ofof social
begins
toto
As the
the relatively
relatively
new idea
ideaincreasingly
social media
media
beginsfor
expand,
it has new
become
important
expand,
it
has
become
increasingly
important
for
expand,
it
has
become
increasingly
important
businesses to get on board. Social Media Networking isfor
businesses
get
isis
businesses
geton
onboard.
board.
Social
MediaNetworking
Networking
no
longer toto
only
present
inSocial
the Media
home,
but in the
no
longer
only
present
in
the
home,
but
in
the
no
longer
only
present
in
the
home,
but
in
the
professional world as well. The Power of “Like” Session
professional
as
well.
ofof“Like”
Session
professional
world
as
well.The
ThePower
Powerfrom
“Like”
Session
will
introduceworld
social
media
marketing
a laboratory
will
social
from
willintroduce
introduceand
social
mediamarketing
marketingtactics
fromafor
alaboratory
laboratory
perspective,
will media
include
strategic
success
perspective,
and
will
strategic
tactics
for
perspective,
andrecruitment
willinclude
includetools,
strategic
tactics
forsuccess
success
such
as online
tracking
your
impact,
such
as
online
recruitment
tools,
tracking
your
such as
online
tracking establishing
yourimpact,
impact,
going
above
andrecruitment
beyond thetools,
competition,
going
and
the
establishing
goingabove
above
andbeyond
beyond
thecompetition,
competition,
establishing
goals,
and ways
to
effectively
reach out to
potential
goals,
toto effectively
reach
goals, and
andinways
ways
effectively
reach out
out toto potential
potential
customers
the online
world.
customers
customersininthe
theonline
onlineworld.
world.
W5. High Stakes Drug Testing in the
W5
W5.
Stakes
W5.High
High(B)
StakesDrug
DrugTesting
Testingininthe
the
Neonate
Neonate
Neonate(B)
(B)
Steven W. Cotten, PhD, DABCC, NRCC
Steven
PhD,
StevenW.
W.Cotten,
Cotten,
PhD,DABCC,
DABCC,NRCC
NRCC
Assistant
Professor
Pathology
Assistant
Professor
Pathology
Assistant
Professor
Pathology
Ohio
State
University
Wexner Medical Center
Ohio
OhioState
StateUniversity
UniversityWexner
WexnerMedical
MedicalCenter
Center
Drug testing in newborns comes with analytical,
Drug
inin legal
newborns
with
Drug testing
testingand
newborns
comes
with analytical,
analytical,
therapeutic,
issues,comes
and interpretation
of
therapeutic,
legal
interpretation
ofof
therapeutic,
andleft
legal
issues, and
andnurses,
interpretation
results
may and
be
to issues,
physicians,
or social
results
be
toto physicians,
nurses,
oror social
results may
may
be left
leftThe
physicians,
nurses,and
social
services
workers.
unique
analytical
legal
services
workers.
The
unique
analytical
and
services pose
workers.
The of
unique
analytical
and legal
legal
caveats
a variety
challenges
and therapeutic
caveats
pose
a
variety
of
challenges
and
therapeutic
caveatsfor
pose
a variety
of challenges
andresults
therapeutic
issues
providers
because
laboratory
can
issues
because
can
issues for
for providers
providersnewborns
because laboratory
laboratory
results
can
potentially
remove
from
theirresults
biological
potentially
remove
newborns
from
their
biological
potentially
remove
newborns
from
their
biological
parents.
parents.
parents.
W6. Evaluation of AIDS Gene Therapy
W6.
W6
W6.Evaluation
Evaluation
ofAIDS
AIDS
GeneTherapy
Therapy
strategies
by a of
group
ofGene
High
School
and
strategies
by
a
group
of
High
School
and
strategies
by
a
group
of
High
School
and
Community College Students in
a Science
Community
ininaaScience
CommunityCollege
CollegeStudents
Students
Science
enrichment
program.
(B)
enrichment
enrichmentprogram.
program.(B)
(B)
Harry Kestler, PhD
Harry
PhD
HarryKestler,
Kestler,
PhD
Professor
of Microbiology
Professor
ofofMicrobiology
Professor
Microbiology
Lorain
County
Community College
Lorain
LorainCounty
CountyCommunity
CommunityCollege
College
Seven years ago, a scientific learning community was
Seven
ago,
learning
community
was
Sevenyears
years
ago,aan
ascientific
scientific
learning
community
was
developed
around
HIV research
project.
Since then
developed
around
research
project.
then
developed
aroundan
anHIV
HIVstudents
researchand
project.
Since
then
over
25 undergraduate
overSince
20 high
over
undergraduate
and
over
20
over 25
25have
undergraduate
students
andare
over
20 high
high
schools
participated.students
The
students
looking
into
schools
have
participated.
The
students
are
looking
into
schools
have
participated.
The
students
are
looking
into
the nature of natural mutations of CCR5 a co-receptor
the
thenature
natureofofnatural
naturalmutations
mutationsofofCCR5
CCR5aaco-receptor
co-receptor
7
for
for HIV
HIV and
and mediator
mediator of
of inflammatory
inflammatory signals.
signals. The
The
students
students constructed
constructed expression
expression vectors
vectors for
for examining
examining
the
the effect
effect of
of the
the alleles.
alleles.
W7. Laboratory Competency (I)
W7
Ruth Natali, MT (ASCP), SH
Core
Core Lab
Lab Operations
Operations Manager
Manager
University
University Hospitals
Hospitals Case
Case Medical
Medical Center
Center
This
as a
a guide
This session
session will
will serve
serve as
guide to
to fulfilling
fulfilling CAP
CAP
Competency requirements.
Competency
requirements. We
We will
will define
define the
the essential
essential
elements
elements required
required to
to fulfill
fulfill the
the CAP
CAP competency
competency
requirements
requirements and
and discuss
discuss ways
ways to
to design
design “test
“test systems”
systems”
that
that fit
fit your
your laboratory’s
laboratory’s structure.
structure. Specific
Specific examples
examples of
of
successful
successful methods
methods to
to document
document all
all elements
elements of
of
competency
competency assessment
assessment will
will be
be shared.
shared.
W8. How do we get physicians to order the
W8
right test? (B)
Eugenio H. Zabaleta, PhD
Clinical
Clinical Chemist
Chemist
MedCentral
MedCentral Health
Health System
System
Healthcare
Healthcare reform
reform seeks
seeks to
to make
make expenditures
expenditures more
more
efficient
efficient and
and targeted,
targeted, among
among other
other things.
things. Through
Through the
the
implementation
implementation of
of Information
Information Technology
Technology (IT)
(IT) Health
Health
Care
Care Institutions
Institutions have
have the
the potential
potential to
to improve
improve laboratory
laboratory
test
test utilization,
utilization, improve
improve patient
patient safety,
safety, decrease
decrease errors
errors
and
and reduce
reduce length
length of
of stay,
stay, all
all of
of which
which are
are metrics
metrics that
that
can
can be
be used
used in
in assessing
assessing implementation
implementation of
of reforms.
reforms.
W9. Where the data lives: Data
W9
Warehousing, Virtualization and “cloud”
services in the modern Lab (I)
Arkadiy Kheyfets, MS.Eng, PMP, CISSP,
CCDA
Denise M. O’Conner, MT(ASCP), Six Sigma
Black Belt, Lean Healthcare Certified
Senior
Senior Manager,
Manager, Healthcare
Healthcare Solutions
Solutions
Siemens
Siemens Healthcare
Healthcare Diagnostics,
Diagnostics, Inc.
Inc.
Lean
Lean Six
Six Sigma
Sigma is
is becoming
becoming a
a necessity
necessity for
for survival
survival in
in
the
healthcare
industry.
Pressure
is
the healthcare industry.
Pressure is constantly
constantly
increasing
increasing to
to provide
provide the
the highest
highest quality
quality results
results in
in a
a
shorter
shorter time
time frame
frame at
at the
the lowest
lowest possible
possible cost.
cost. Gain
Gain an
an
understanding
understanding of
of the
the fundamentals
fundamentals and
and tools
tools of
of Lean
Lean Six
Six
Sigma,
Sigma, how
how these
these tools
tools and
and principles
principles are
are used
used to
to
drastically
drastically reduce
reduce defects,
defects, delays
delays and
and deviation,
deviation, and
and
how
how to
to sustain
sustain improvements
improvements once
once they
they are
are
implemented.
implemented.
Sponsored
Sponsored by
by Siemens
Siemens
T11 Hemoglobin A1c for the diagnosis of
T11.
diabetes (B)
Sihe Wang, PhD, DABCC, FACB
Head,
Head, Section
Section of
of Clinical
Clinical Biochemistry
Biochemistry
Cleveland
Clinic
Cleveland Clinic
Though
Though blood
blood hemoglobin
hemoglobin A1c
A1c has
has been
been accepted
accepted as
as a
a
diagnostic
diagnostic test
test for
for diabetes
diabetes there
there are
are issues
issues with
with this
this
biomarker
biomarker that
that both
both the
the Laboratorians
Laboratorians and
and clinicians
clinicians
need
need to
to be
be aware
aware of.
of. In
In this
this presentation,
presentation, pros
pros and
and cons
cons
of
of using
using HgbA1c
HgbA1c for
for diagnosis
diagnosis of
of diabetes
diabetes will
will be
be
discussed.
discussed. Current
Current available
available methods
methods of
of measuring
measuring
HgbA1c
HgbA1c will
will also
also be
be presented.
presented.
T12
T12. Is the Current Lab Business Model at a
Strategic Inflection Point? (B)
Khosrow Shotorbani, MBA, MT(ASCP)
Vice
Vice President,
President, Director
Director of
of Business
Business Innovations
Innovations
ARUP
Laboratories
ARUP Laboratories
Outline
Outline of
of Information
Information Systems
Systems layout
layout in
in the
the modern
modern
mid-range
mid-range clinical
clinical laboratory.
laboratory. Minimizing
Minimizing IT
IT footprint
footprint and
and
decreasing
decreasing cost
cost while
while increasing
increasing systems
systems and
and services
services
availability
availability due
due to
to making
making smart
smart choices.
choices. This
This
presentation
will
cover
which
systems
to
virtualize,
presentation will cover which systems to virtualize, which
which
systems
systems and
and services
services to
to move
move to
to the
the cloud
cloud and
and how
how to
to
make
data
flow
secure
and
reliable
in
between.
make data flow secure and reliable in between.
Coordinating
Coordinating primary
primary care
care services
services and
and facilitating
facilitating
collaboration
across
different
providers
and
collaboration
across
different
providers
and
organizations
organizations are
are key
key objectives
objectives of
of patient-centered
patient-centered
medical
medical homes
homes and
and accountable
accountable care
care organizations
organizations
(ACOs)
under
healthcare
reform.
Understanding
(ACOs) under healthcare reform. Understanding how
how
these
these two
two models
models redefine
redefine the
the economic
economic value
value of
of
diagnostic
diagnostic testing
testing where
where patient
patient care
care is
is integrated
integrated and
and
value
value is
is rewarded
rewarded over
over volume
volume helps
helps bring
bring into
into clearer
clearer
focus
focus a
a shifting
shifting paradigm
paradigm for
for lab
lab organizations,
organizations, which
which will
will
result
result in
in new
new industry
industry winners
winners and
and losers.
losers.
T10.
T10
Sponsored
Sponsored by
by ARUP
ARUP Laboratories
Laboratories
Director
Director of
of IT
IT
Cleveland
Cleveland HeartLab
HeartLab Inc.
Inc.
Lean Six Sigma: Eliminating the 3 D’s
(Delay, Defects, and Deviation) to Produce
Better, Faster, More Profitable Results (B)
8
T13. Effective Educational Modalities in
T13
Clinical Allied Health Education (B)
Craig Clifford, MD, MS
Clinical
Clinical Medical
Medical Assisting
Assisting Instructor
Instructor
Ohio
Ohio School
School of
of Phlebotomy
Phlebotomy
Prenatal
Prenatal Screening
Screening has
has come
come aa long
long way
way in
in 30
30 years.
years.
From
From maternal
maternal serum
serum alpha
alpha fetoprotein
fetoprotein (MSAFP)
(MSAFP) alone
alone
for
for neural
neural tube
tube defect
defect screening
screening only
only (NTD),
(NTD), the
the addition
addition
of
of analytes
analytes to
to screen
screen for
for Down
Down syndrome
syndrome and
and now
now to
to the
the
use
use of
of free
free fetal
fetal DNA
DNA in
in maternal
maternal plasma
plasma to
to screen
screen for
for
chromosome
chromosome abnormalities,
abnormalities, the
the prenatal
prenatal screening
screening world
world
remains
remains full
full of
of choices.
choices.
The
The Ohio
Ohio School
School of
of Phlebotomy’s
Phlebotomy’s (OSP)
(OSP) clinical
clinical medical
medical
assisting
assisting instructor
instructor discusses
discusses the
the problems
problems and
and solutions
solutions
to
to educational
educational differentials
differentials in
in diverse
diverse student
student
populations.
populations. Enlisting
Enlisting the
the aid
aid of
of an
an early
early education
education and
and
development
development teacher
teacher an
an objective
objective non-stratified
non-stratified
paradigm
paradigm is
is presented
presented in
in order
order to
to equally
equally engage
engage the
the
students
students from
from all
all educational
educational backgrounds.
backgrounds.
T17
T17. Recurrent infections in an Adult or a
T14. KEYNOTE: Working Together: Moving
T14
Thomas S. Alexander, PhD, D(ABMLI)
from Me to We (B)
Nancy J Riesz, MBA, MT(ASCP), ACC
President
President
Success
Success Catalyst
Catalyst
In
In today’s
today’s world
world of
of rapid
rapid technological
technological and
and social
social
change,
change, teamwork
teamwork is
is not
not aa luxury.
luxury. ItIt is
is aa necessity.
necessity. Yet,
Yet,
establishing
establishing teamwork
teamwork in
in the
the laboratory
laboratory is
is not
not always
always
easy.
easy. ItIt requires
requires commitment,
commitment, cooperation
cooperation and
and effort,
effort, as
as
well
well as
as aa willingness
willingness to
to accept
accept and
and appreciate
appreciate the
the
uniqueness
uniqueness of
of others.
others. This
This inter-active
inter-active session
session shares
shares
specific
specific skills
skills and
and provides
provides solutions
solutions for
for working
working
better….
better…. together.
together.
T15 No, really, what is this patient’s blood
T15.
type?! (I)
Suzanne Bakdash, MD, MPH
Staff
Staff Physician,
Physician, Sections
Sections of
of Transfusion
Transfusion Medicine
Medicine and
and
Hemostasis
Hemostasis &
& Thrombosis
Thrombosis
Cleveland
Cleveland Clinic
Clinic
ABO
ABO blood
blood types
types are
are determined
determined by
by identifying
identifying and
and
comparing
comparing ABO
ABO antigens
antigens on
on aa patient’s
patient’s red
red blood
blood cells
cells
(forward
(forward typing)
typing) with
with antibodies
antibodies in
in their
their plasma
plasma (reverse
(reverse
typing).
typing). Blood
Blood type
type discrepancies
discrepancies arise
arise when
when the
the forward
forward
and
and reverse
reverse types
types don’t
don’t match!
match! This
This presentation
presentation will
will
review
review the
the fundamentals
fundamentals of
of ABO
ABO blood
blood type
type
determination
determination and
and discuss
discuss case
case examples
examples of
of ABO
ABO typing
typing
discrepancies.
discrepancies.
T16. Prenatal Screening 101 (B)
T16
Christine Wensel, MS, CGC
Genetic
Genetic Counselor
Counselor
University
University Hospitals
Hospitals Case
Case Medical
Medical Center
Center –– Center
Center for
for
Human
Human Genetics
Genetics Laboratory
Laboratory
Kid? It might be a PID! Clinical and
Laboratory Update on Primary Immune
Deficiencies (I)
Immunologist
Immunologist
Summa
Summa Health
Health System
System
Over
Over 150
150 primary
primary immune
immune deficiencies
deficiencies (PID)
(PID) have
have been
been
described.
described.
These
These diseases
diseases are
are associated
associated with
with
diagnostic
diagnostic dilemmas
dilemmas and
and confusing
confusing board
board questions.
questions.
This
This talk
talk describes
describes the
the major
major classes
classes of
of PIDs,
PIDs, the
the more
more
common
common PIDs,
PIDs, and
and presents
presents diagnostic
diagnostic algorithms,
algorithms,
including
including newer
newer molecular
molecular assays.
assays. Clinical
Clinical case
case
presentations
presentations will
will be
be used
used to
to highlight
highlight specific
specific diseases.
diseases.
T18 Pediatric Blood Sparing: An
T18.
interdisciplinary quality improvement
initiative to standardize and minimize blood
sampling volumes and reduce preanalytical testing errors. (I)
Paula L. Forsythe, MSN, RN, CNS
Clinical
Clinical Nurse
Nurse Specialist
Specialist for
for Neonatal
Neonatal Services
Services
Rainbow
Rainbow Babies
Babies and
and Children’s
Children’s Hospital,
Hospital, University
University
Hospitals
Hospitals Case
Case Medical
Medical Center
Center
Pediatric
Pediatric Blood
Blood Sample
Sample Guidelines
Guidelines were
were standardized
standardized
for
for more
more than
than 50
50 of
of the
the most
most frequent/essential
frequent/essential pediatric
pediatric
blood
blood tests,
tests, including
including blood
blood bank
bank specimens.
specimens. Guidelines
Guidelines
include
include appropriate
appropriate tube
tube selection
selection and
and special
special handling
handling
requirements.
requirements. This
This interdisciplinary,
interdisciplinary, problem-solving
problem-solving
approach
approach resulted
resulted in
in improvement
improvement in
in the
the quality
quality and
and
safety
safety of
of specimen
specimen collection,
collection, improved
improved communication
communication
between
between disciplines,
disciplines, and
and reduced
reduced pre-analytical
pre-analytical test
test
errors.
errors.
9
T19
T19. Leadership in an emerging healthcare
organization (B)
Jake Orville
CEO
Cleveland HeartLab, Inc.
How to engage and make an emotional connection with
employees in a high growth, high paced environment.
T20. You Say Apple, I say Orange, An
T20
Attempt to Standardize the Grading of
Hematology Morphology (I)
Catherine Shaffner, MLS(ASCP)CMSH
Education Coordinator
ProMedica
Ideally, within a laboratory, standardized definitions and
reporting format should be employed – but are they?
How do you even attempt to ensure everyone calls an
apple an apple?
All major aspects of red cell
morphology are reviewed in this richly illustrated
interactive course that uses numerous photomicrographs
to identify and heighten study of morphologic
abnormalities in red cell size, shape, and color. This
course is ideal for review by techs and students and use
in continuing education and cross training.
T21
T21. Health Care Reform Status Report – 3
years since PPACA signed into law (I)
Paul Labbe, Masters in Clinical Laboratory
Technology (MCLT)
V.P. Hospital Solutions
CompuNet Clinical Laboratories
Discussion/debate of the Patient Protection and
Affordable Care Act (PPACA) and the changes and
impact to the initial reform proposals along with the
deletions, revisions to be expected from such a
comprehensive package of reforms. The PPACA was
signed into law on March 23, 2010 and the US Supreme
Court upheld the constitutionality of most of the PPACA
on June 28, 2012. Review of what is in place and what
is still planned for implementation will be presented.
T22.
T22 Moving on Up! Fast Track & Career
Paths for Phlebotomists (I)
Elaine Ewald
VP Specimen Collection & Processing
CompuNet Clinical Laboratories
10
Terrie McManes
Director Patient Services
CompuNet Clinical Laboratories
This program will outline the use of Career Path and
Fast Track to reward phlebotomists for achieving
increasing skills levels and experience in both inpatient
and outpatient setting.
Sponsored by CompuNet Clinical Laboratories
T23. How Reproductive Laboratories Differ
T23
from Clinical Laboratories (I)
Doris J. Baker, PhD, MT (ASCP), HCLD
(ABB), Emb-Acad. (ACE)
Professor
University of Kentucky
Discussion of the differences and similarities between
reproductive
laboratories
and
clinical
laboratories. Topics include the andrology and
embryology procedures performed, such as semen
analysis, in vitro fertilization, gamete and embryo
cryopreservation, numbers of each facility type, specific
personnel requirements, and the regulatory/certification
agencies involved.
T24.
T24 Pediatric Phlebotomy (I)
Randy Gruhlke BS, CPT, (NHA)
Associate Program Director – Phlebotomy Program,
Mayo School of Health Sciences
Education Specialist – Clinical Core Laboratory Services
Mayo Clinic
This presentation will reveal the intricacies related to
pediatric phlebotomy; included in the discussion, the
relevance and effectiveness of communication with the
pediatric patient, the role the parents play in pediatric
phlebotomy, collection equipment choices, techniques,
restraints and specimen concerns including collection
volumes and the value of a dedicated pediatric
phlebotomy staff.
Sponsored by Mayo Medical Laboratories
T25
T25. Are These Lab Values Accurate?
Evaluating Laboratory Results with
Specimen Quality (I)
Sandra VanVranken, MS, MT(ASCP)SH
Laboratories
Laboratories Compliance
Compliance Manager
Manager
The
The Ohio
Ohio State
State University
University Wexner
Wexner Medical
Medical University
University
Center
Center
This
This presentation
presentation reviews
reviews aa variety
variety of
of pre-analytical
pre-analytical
conditions
conditions that
that can
can lead
lead to
to inaccurate
inaccurate laboratory
laboratory results.
results.
The
The participants
participants will
will discuss
discuss how
how problems
problems with
with
specimen
specimen quality
quality directly
directly correlate
correlate to
to extreme
extreme laboratory
laboratory
results.
results. Many
Many case
case studies
studies in
in specimen
specimen quality
quality will
will be
be
discussed,
discussed, along
along with
with typical
typical laboratory
laboratory results
results that
that are
are
produced.
produced. Examples
Examples include;
include; IV
IV contaminated
contaminated
specimens,
specimens, hemolyzed
hemolyzed specimens,
specimens, clotted
clotted specimens,
specimens,
improper
improper temperatures
temperatures for
for storage,
storage, effect
effect of
of
anticoagulation,
anticoagulation, etc.
etc.
T26. A tale of two algorithms: Laboratory
T26
diagnosis of HIV and Treponema pallidum
infection. (I)
Mario J Marcon, PhD, D(ABMM),
Director,
Director, Clinical/Molecular
Clinical/Molecular Microbiology,
Microbiology, Virology,
Virology,
Immunoserology
Immunoserology Labs
Labs
Nationwide
Nationwide Children's
Children's Hospital
Hospital
Clinical
Clinical Professor
Professor of
of Pediatrics
Pediatrics and
and Pathology
Pathology
Ohio
Ohio State
State University
University College
College of
of Medicine
Medicine
Laboratory
Laboratory diagnosis
diagnosis of
of HIV
HIV and
and Treponema
Treponema pallidum
pallidum
infections
infections have
have traditionally
traditionally relied
relied on
on serologic
serologic
“screening”
“screening” assays
assays followed
followed by
by supplemental
supplemental serologic
serologic
tests
tests to
to establish
establish the
the diagnosis.
diagnosis. Such
Such traditional
traditional “2-step”
“2-step”
algorithms
algorithms generally
generally call
call for
for performing
performing aa less
less complex
complex
test
test first
first followed
followed by
by aa more
more technologically
technologically complex
complex test
test
ifif the
the initial
initial test
test is
is positive.
positive. Such
Such an
an approach
approach often
often
leads
leads to
to delays
delays in
in reporting
reporting of
of final
final test
test results
results and
and thus
thus
may
may negatively
negatively impact
impact patient
patient care.
care. Recent
Recent studies
studies have
have
supported
supported the
the use
use of
of 4th
4th generation
generation antibody/antigen
antibody/antigen
screening
screening EIAs
EIAs coupled
coupled with
with alternative
alternative serologic
serologic tests
tests
to
to replace
replace Western
Western blot
blot for
for confirming
confirming HIV
HIV infection,
infection, as
as
well
well as
as the
the use
use of
of nucleic
nucleic acid
acid amplification
amplification diagnostic
diagnostic
tests.
tests. Similarly,
Similarly, aa so-called
so-called “reverse
“reverse algorithm”
algorithm” for
for T.
T.
pallidum
pallidum infection,
infection, whereby
whereby aa treponemal
treponemal test
test is
is
performed
performed first
first to
to be
be followed
followed by
by aa nontreponelal
nontreponelal test
test ifif
positive,
positive, has
has been
been studied
studied for
for the
the serologic
serologic diagnosis
diagnosis of
of
syphilis.
syphilis. This
This presentation
presentation will
will provide
provide an
an update
update to
to
available
available current
current guidelines
guidelines for
for diagnosis
diagnosis of
of HIV
HIV and
and T.
T.
pallidum
pallidum infection.
infection.
T27.
T27 What Next? I want or need a new job!
(B)
James A. Rowe, MBA, HT, MT (ASCP),
FACHE
Operations
Operations Manager
Manager
AmeriPath
AmeriPath (A
(A Division
Division of
of Quest)
Quest)
Tips
Tips and
and experiences
experiences on
on the
the job
job search,
search, the
the telephone
telephone
interview,
interview, and
and even
even some
some thoughts
thoughts on
on what
what to
to think
think
about
about ifif you
you are
are placed
placed on
on corrective
corrective action
action or
or let
let go
go
from
from your
your job.
job.
T28.
T28 Critical Values: Cutoffs,
Communication, and Impact on Care (B)
Christine Schmotzer, MD
Director
Director of
of Clinical
Clinical Chemistry
Chemistry
University
University Hospitals
Hospitals Case
Case Medical
Medical Center
Center
Critical
Critical value
value communication
communication is
is aa key
key focus
focus of
of The
The Joint
Joint
Commission
Commission National
National Patient
Patient Safety
Safety Goals.
Goals.
This
This
session
session will
will cover
cover common
common critical
critical values
values challenges
challenges
including
including identification
identification of
of resources
resources for
for determining
determining
critical
critical value
value cutoffs;
cutoffs; comparison
comparison of
of models
models for
for
communication
communication and
and documentation
documentation of
of critical
critical results
results (call
(call
centers,
centers, automated
automated notification
notification systems,
systems, or
or bench
bench
technologists);
technologists); and
and current
current recommendations
recommendations on
on
benchmark
benchmark notification
notification times
times and
and repeating
repeating critical
critical tests
tests
results.
results.
T29.
T29 Laboratory Monitoring of Heparin
Therapy (I)
Kathy Shingler, MT(ASCP)
Clinical
Clinical Hemostasis
Hemostasis Specialist
Specialist
Instrumentation
Instrumentation Laboratory
Laboratory
This
This session
session will
will discuss
discuss heparin
heparin anticoagulant
anticoagulant therapy
therapy
and
and the
the challenges
challenges the
the laboratory
laboratory faces
faces in
in determining
determining aa
true
true therapeutic
therapeutic range
range and
and meeting
meeting guidelines.
guidelines. Various
Various
methods
methods for
for establishing
establishing aa range
range are
are discussed
discussed as
as well
well
as
as the
the value
value for
for monitoring
monitoring heparin
heparin using
using Anti-Xa.
Anti-Xa.
Monitoring
Monitoring with
with Anti-Xa
Anti-Xa has
has been
been shown
shown that
that patients
patients
are
are within
within therapeutic
therapeutic range
range faster
faster than
than monitoring
monitoring with
with
APTT.
APTT. Discussion
Discussion will
will take
take place
place as
as to
to how
how your
your lab
lab can
can
transition
transition to
to this
this method
method of
of heparin
heparin monitoring.
monitoring.
Sponsored
Sponsored by
by Instrumentation
Instrumentation Laboratory
Laboratory
11
F30 Reviewing and Revising Reference
F30.
Intervals: Challenges and Options (B)
Amy L. Pyle, PhD, DABCC
Assistant Director of Core Laboratory
Nationwide Children's Hospital
Establishing and renewing reference intervals can be a
challenge to laboratorians, so that many just blindly use
existing or published ranges. There’s a better way,
though, and it can be accomplished without too much
work. This talk will review the principles of establishing,
verifying, and transferring reference intervals.
F31. Rapid Identification of Blood Culture
F31
Isolates (I)
Ike Northern, MT, M (ASCP), MS
Microbiology
Director of Infectious Disease Testing
CompuNet Clinical Laboratories
Rapid identification of blood culture isolates can have a
major impact on patient care, patient outcome, and
length of hospital stay. There are numerous options for
performing rapid identification on these isolates. This
talk will discuss these options, taking into consideration
the sensitivity, ease of use, and cost.
F32 Metabolic Acidosis & Metabolic
F32.
Alkalosis (I)
Michael D. Patterson, DO
Vice President, Chief Medical Officer
MedCentral Health System
Although buffers in the body fluids help resist changes in
the pH of body fluids, the respiratory system and the
kidneys regulate the pH of the body fluids. Malfunctions
of either the respiratory system or the kidneys can result
in acidosis or alkalosis with life threatening
consequences. This talk will explore the causes and
effects of metabolic acidosis and alkalosis, as well as the
body's compensation mechanisms
F33 Clotting or Bleeding? A Case StudyF33.
Based Review of Hemostasis (I)
Charity Accurso, PhD MT(ASCP)
Interim Program Director, Medical Laboratory Science
Program
University of Cincinnati
12
This session will be a case study-based review of
Hemostasis. Through the review of a series of case
studies, we will review normal and abnormal physiology
of hemostasis, as well as the diagnostic strategies for
diagnosis.
F34 ASCP Board of Certification
F34.
Examinations and Certification
Maintenance Program (I)
Susan L. Wilkinson, EdD, MT(ASCP)SBBCM
Interim Department Head, Analytical and Diagnostic
Sciences, College of Allied Health Sciences, and
Associate Professor Emerita
University of Cincinnati
The ASCP Board of Certification criterion-referenced
examination model and the computer adaptive testing
strategy will be reviewed. Statistics for the MLT, MLS
and DLM examinations will be reviewed over a 10-year
period. These statistics will include: numbers of
individuals who took the exam, percentages of those
who successfully achieved certification, and the
percentage of NAACLS 1st time test takers who
successfully achieved certification. Various routes to
take the MLT, MLS and DLM examinations will be
reviewed and the Certification Maintenance Program will
be described.
F35
F35. Controlling Genetic Test Send Out
Volume (I)
Patty Taneja, MS, CGC
Supervisor
Center for Human Genetics Laboratory - University
Hospitals of Cleveland
Genetic testing is more available and more affordable
than ever. No lab offers a comprehensive test menu,
thus sending samples to other laboratories is a common
practice. Paired with increasing issues with insurance
coverage, a tug of war exists between appropriate
ordering and resource allocation. This talk highlights the
practices put into place to address this, and the lessons
learned.
F36 Trauma Packs & Massive
F36.
Transfusions, What to Do? (I)
Suzanne H. Butch, MA, MLS(ASCP)CM,
SBBCM
Administrative Manager, Blood Bank & Transfusion
Service and Compliance Manager
University of Michigan Hospitals & Health Centers
This session will review the benefits and challenges
associated with protocols for trauma packs and massive
transfusions
both
large and
This
sessionforwill
review
the smaller
benefitsinstitutions.
and challenges
associated with protocols for trauma packs and massive
transfusions
both large
and smaller
institutions.
F37. BloodforGases
– Let’s
Get Clinical
(I)
Erik Gallion, RCP/RRT
F37
F37.
Blood Gases – Let’s Get Clinical (I)
Manager Cardiac/Vascular and Pulmonary Services
MedCentral
Health
System
Erik
Gallion,
RCP/RRT
Manager Cardiac/Vascular and Pulmonary Services
Normal blood
pH must
be maintained within a narrow
MedCentral
Health
System
range of 7.35-7.45 to ensure the proper functioning of
metabolic
processes
andbe
themaintained
delivery of the
right
Normal
blood
pH must
within
a amount
narrow
of oxygen
to tissues.
This talk
review
acid-base
range
of 7.35-7.45
to ensure
the will
proper
functioning
of
disorders due
to lungand
diseases
or conditions
that
affect
metabolic
processes
the delivery
of the right
amount
normal
breathing,
andThis
cause
in acid-base
the CO2
of
oxygen
to tissues.
talk changes
will review
concentration.
disorders due to lung diseases or conditions that affect
normal breathing, and cause changes in the CO2
concentration.
F38. Drug Screening for Pain Management
M. S. Stegall & Associates, LLC
In this
era of&Accountable
Care, Hospital providers will
M.
S. Stegall
Associates, LLC
be facing significant revenue shrinkage from all payers.
As this
revenue
up, so does
funding
for new
In
era ofdries
Accountable
Care,internal
Hospital
providers
will
capital
initiatives.
Internal
competition
for
scarce
capital
be facing significant revenue shrinkage from all payers.
dollars
will be
fierce.
session
will teach
youfor
how
to
As
revenue
dries
up,This
so does
internal
funding
new
developinitiatives.
compellingInternal
business
cases andforpresent
to
capital
competition
scarcethem
capital
senior leadership
to obtain
requiredwill
funding.
dollars
will be fierce.
This session
teach you how to
develop compelling business cases and present them to
senior
leadership
required funding.
F41. A
review to
ofobtain
antimicrobial
susceptibility
F41
testing methods (I)
F41. A review of antimicrobial susceptibility
Joel Mortensen, MLT (AMT), PhD
testing
methods (I)
Director, Diagnostic Infectious Diseases Testing
Laboratories
Joel
Mortensen, MLT (AMT), PhD
University
Hospitals Departments
Case Medical of
Center
Senior
Instructor,
Anesthesiology &
Psychiatry
Review of Hospitals
clinical indications
and Center
current guidelines for
University
Case Medical
when a Urine Drug Screen would be indicated in a
patient. of
A review
risk stratification
and guidelines
frequency for
of
Review
clinical of
indications
and current
screening
will
be
presented.
when a Urine Drug Screen would be indicated in a
patient. A review of risk stratification and frequency of
screening
will be presented.
F39. Molecular
Genetics of
Cincinnati Children's
Director,
DiagnosticHospital
Infectious Diseases Testing
Professor, Department of Pathology and Laboratory
Laboratories
Medicine Children's Hospital
Cincinnati
University ofDepartment
Cincinnati of Pathology and Laboratory
Professor,
Medicine
One area of
microbiology has more impact on the
University
of clinical
Cincinnati
care of our patients, yet may get the least attention. In
the era
antibiotics
more
antibiotic
One
areaofof fewer
clinical new
microbiology
hasand
more
impact
on the
resistance,
every
medical
technologist
needs
to
care of our patients, yet may get the least attention. In
understand
the
basics
of
the
methods
used
today.
Each
the era of fewer new antibiotics and more antibiotic
method or every
systemmedical
has itstechnologist
own strengths
resistance,
needs and
to
weaknessesthe
- which
is the
right one?
This session
understand
basicsone
of the
methods
used today.
Each
will review
methods
results in and
this
method
or the
system
hasanditskinds
own of strengths
critical area of- microbiology.
weaknesses
which one is the right one? This session
will review the methods and kinds of results in this
Sponsored
bymicrobiology.
Meridian Bioscience
critical
area of
F39
F39.
Molecular Genetics
of
Myelodysplastic
– New Discoveries
Explain
Sponsored
by Meridian
F42. Laboratories
inBioscience
Developing Countries:
F42
Therapeutic
Sciences PhD, MLS
J.
Lynne Williams,
Pathology
B.
LaurelDepartment,
Elder, PhDBoonshoft School of Medicine,
(I)
F38
F38. Drug Screening for Pain Management
Binit J. Shah, MD
(I)
Senior Instructor, Departments of Anesthesiology &
Psychiatry
Binit
J. Shah, MD
Myeloproliferative Neoplasms and
Myeloproliferative
Neoplasms and
Old Observations (I)
Myelodysplastic – New Discoveries Explain
J. Lynne Williams, PhD, MLS
Old
Observations (I)
Professor & Program Director, Biomedical Diagnostic &
Oakland University
Professor
& Program Director, Biomedical Diagnostic &
Therapeutic Sciences
ImprovedUniversity
molecular analyses over the past several
Oakland
years have resulted in the identification of new genes
involved molecular
in
myelodysplastic
and
Improved
analyses over syndromes
the past several
myeloproliferative
neoplasms.
A better understanding
of
years
have resulted
in the identification
of new genes
the
molecular
basis
of
these
disorders
is
resulting
in
new
involved
in
myelodysplastic
syndromes
and
therapeutic approaches.
myeloproliferative
neoplasms. A better understanding of
the molecular basis of these disorders is resulting in new
therapeutic
approaches.
F40. Develop
a Business Case That Will Get
Your Initiative Funded (I)
F40
F40. Develop a Business Case That Will Get
M. Susan Stegall, Certified Management
Your Initiative Funded (I)
Consultant, MBA, MHSA, MT(ASCP)
Owner
& CEO Stegall, Certified Management
M.
Susan
Consultant, MBA, MHSA, MT(ASCP)
Owner & CEO
M. S. Stegall & Associates, LLC
In this era of Accountable Care, Hospital providers will
be facing significant revenue shrinkage from all payers.
As revenue dries up, so does internal funding for new
capital initiatives. Internal competition for scarce capital
dollars will be fierce. This session will teach you how to
develop compelling business cases and present them to
senior leadership to obtain required funding.
A Cambodian Experience (B)
F42. Laboratories in Developing Countries:
B. Laurel Elder, PhD
A
Cambodian Experience (B)
Associate Professor
Wright State
University
Associate
Professor
Pathology Department, Boonshoft School of Medicine,
Cambodia
faced tremendous challenges, including
Wright
Statehas
University
genocide and civil unrest, as it strives to develop a
health carehas
infrastructure.
Laboratories
in Cambodia
are
Cambodia
faced tremendous
challenges,
including
just now beginning
to develop
facilities
that will
genocide
and civil unrest,
as it into
strives
to develop
a
supportcare
patient
care. Laboratories
This talk will
share one
health
infrastructure.
in Cambodia
are
microbiologist’s
three-month
experience
helpingthat
to train
just
now beginning
to develop
into facilities
will
microbiologists
in
Cambodia
as
a
volunteer
with
the
support patient care.
This talk will share one
Diagnostic
Microbiology
Development
Program.
microbiologist’s three-month experience helping to train
microbiologists in Cambodia as a volunteer with the
Diagnostic
Microbiology
Program. (I)
F43. Vaccination
IsDevelopment
Not Immunization
F43
Kathy V. Waller, PhD, MLS(ASCP)
F43.
Vaccination Is Not Immunization (I)
Associate Professor
The
OhioV.State
University
Kathy
Waller,
PhD, MLS(ASCP)
Associate Professor
Whether or not to vaccinate one’s child is a critical
decision a parent must make. Newborns and babies
have not yet developed the neurological system, yet may
be subjected to 22 vaccines by 6 months of age and 68
total vaccines by 12 years. In this session, participants
will discuss the risks and benefits of vaccines.
13
F44. What to do with the new technology
and molecular methods in clinical
The Ohio State University
The Ohio or
State
Whether
notUniversity
to vaccinate one’s child is a critical
decision a parent must make. Newborns and babies
have
not yet
the neurological
system,
may
Whether
or developed
not to vaccinate
one’s child
is ayetcritical
be
subjected
to 22 vaccines
by 6 Newborns
months of age
68
decision
a parent
must make.
and and
babies
total
by 12 years.
In this session,
participants
havevaccines
not yet developed
the neurological
system,
yet may
will
discuss thetorisks
and benefits
vaccines.
be subjected
22 vaccines
by 6ofmonths
of age and 68
total vaccines by 12 years. In this session, participants
will discuss
and benefits
of vaccines.
F44.
Whatthe
torisks
do with
the new
technology
F44
and molecular methods in clinical
F44. What to do(I)
with the new technology
microbiology?!
and molecular methods in clinical
Joel
Mortensen, (I)
MLT (AMT), PhD
microbiology?!
Director, Diagnostic Infectious Diseases Testing
Laboratories
Joel Mortensen, MLT (AMT), PhD
Cincinnati
Hospital
Director, Children's
Diagnostic
Infectious Diseases Testing
Professor,
LaboratoriesDepartment of Pathology and Laboratory
Medicine
Cincinnati Children's Hospital
University
Cincinnati of Pathology and Laboratory
Professor,ofDepartment
Medicine
University
Cincinnati
We
are onofthe
cusp of the biggest change in clinical
microbiology since Louis Pasteur declared that life did
not
spontaneously!
There
are more
technologies
We arise
are on
the cusp of the
biggest
change
in clinical
and
methodologies
down the
microbethat
road
microbiology
since coming
Louis Pasteur
declared
lifethan
did
at
time
before.......but There
which ones
will add
value to
notany
arise
spontaneously!
are more
technologies
the
of patients and
which
onesthe
canmicrobe
we afford?
andcare
methodologies
coming
down
road than
at any time before.......but which ones will add value to
Sponsored
by Meridian
Bioscience
the care of patients
and which
ones can we afford?
Sponsored
by Meridian
F45.
Leukemia
CaseBioscience
Studies: the Good, the
F45
Bad and the Ugly (I)
F45. Leukemia Case Studies: the Good, the
Roslyn
McQueen,
PhD, CCRC
Bad and
the Ugly (I)
Certified Clinical Research Coordinator
Hurley
Medical
Center PhD, CCRC
Roslyn
McQueen,
Certified Clinical Research Coordinator
Medical
Center cases will be introduced and
AHurley
number
of leukemia
discussed as to 1) morphologic presentation 2)
laboratory
and 3) final
diagnosis.
discussion
A numberdata
of leukemia
cases
will beOpen
introduced
and
is
encouraged.
discussed
as to 1) morphologic presentation 2)
laboratory data and 3) final diagnosis. Open discussion
is encouraged.
F46
F46.
iPath touch: The Value of Touch
Imprints in Pathology (I)
F46. iPath touch: The Value of Touch
Samir
B. Kahwash,
MD (I)
Imprints
in Pathology
Vice Chair for Education, Department of Pathology
Nationwide
Hospital
Samir B. Children’s
Kahwash,
MD
Vice Chair for Education, Department of Pathology
Nationwide
Children’s
Hospital
This
presentation
will focus
on the value and utilization
of touch imprint interpretation in Clinical and Surgical
Pathology.
This presentation will focus on the value and utilization
of touch imprint interpretation in Clinical and Surgical
Pathology.
14
F47. Project Management Made Easy plus
Fundamentals (B)
F47 Project Management Made Easy plus
F47.
M.
Susan Stegall,
Fundamentals
(B) Certified Management
Consultant, MBA, MHSA, MT(ASCP)
M. Susan
Owner
& CEO Stegall, Certified Management
M.
S. Stegall & Associates,
LLC MT(ASCP)
Consultant,
MBA, MHSA,
Owner & CEO
M. S. Stegall
& Associates,
LLC day of delay is costly.
When
managing
a project, every
Issues become barriers to implementations. Scope
expansion
delaysa project,
implementation
destroys
a
When managing
every day and
of delay
is costly.
project's
return barriers
on investment.
Effective project
Issues become
to implementations.
Scope
management
supports
your organization
enablesa
expansion delays
implementation
and and
destroys
the
people return
within toonorchestrate
a multitude
of initiatives
project's
investment.
Effective
project
in
a professional
andyour
realistic
manner.
Project
management
supports
organization
and enables
management,
when
done right,
enables ofprogress-the people within
to orchestrate
a multitude
initiatives
responsibility,
accountability,
and success.
in a professional
and realistic
manner.
Project
management, when done right, enables progress-responsibility,
accountability,
and success.
F48.
Interferon
Gamma
Release Assays
(IGRAs) in the Diagnosis of Tuberculosis (I)
F48. Interferon Gamma Release Assays
F48
Richard
PhD, D(ABMM)
(IGRAs) B.
in Clark,
the Diagnosis
of Tuberculosis (I)
Scientific Director of Microbiology/Virology
Quest
Diagnostics
Nichols
Institute,
Chantilly
Richard
B. Clark,
PhD,
D(ABMM)
Scientific Director of Microbiology/Virology
Questpresentation
Diagnostics Nichols
Institute,
This
will review
the Chantilly
role of Interferon
Gamma Release Assays (IGRAs) in detecting both
latent
and clinical will
disease
This presentation
reviewdue
the toroleMycobacterium
of Interferon
tuberculosis.
Included
will (IGRAs)
be a discussion
as to both
the
Gamma Release
Assays
in detecting
sensitivity
specificity
of these
(Quantiferon
latent andandclinical
disease
due assays
to Mycobacterium
and
T-Spot)Included
in
detecting
TB
infections.
tuberculosis.
will
be a discussion
as to the
Recommendations
as to when
to use
the IGRAs
will be
sensitivity and specificity
of these
assays
(Quantiferon
discussed.
and
T-Spot)
in
detecting
TB
infections.
Recommendations as to when to use the IGRAs will be
Sponsored
discussed. by Quest Diagnostics
Sponsored
Quest Diagnostics
F49.
BloodbyProduct
utilization & Wastage
(B)
F49 Blood Product utilization & Wastage
F49.
Bob
(B) Reigle, MLS (ASCP)
Transfusion Services Supervisor
MedCentral
Health
System
- Mansfield Hospital
Bob Reigle,
MLS
(ASCP)
Transfusion Services Supervisor
MedCentral Health
System
- Mansfield
Hospital
Transfusion
of blood
products,
including
whole blood,
red blood cells, platelets, plasma and cryoprecipitate, is
an
essential of
part
of patient
care.
Although
thereblood,
are
Transfusion
blood
products,
including
whole
many
clinical
blood product
red blood
cells,practice
platelets,guidelines
plasma andforcryoprecipitate,
is
usage,
the lack
strong
evidence
supportingthere
specific
an essential
partof of
patient
care. Although
are
practices
often leads
to overuse
of blood
With
many clinical
practice
guidelines
for products.
blood product
millions
of blood
products
each yearspecific
in the
usage, the
lack of
strong transfused
evidence supporting
United
improving
utilization
and
decreased
practicesStates,
often leads
to overuse
of blood
products.
With
wastage
it isblood
a critical
aspecttransfused
of transfusion
medicine.
millions of
products
each
year in the
United States, improving utilization and decreased
wastage it is a critical aspect of transfusion medicine.
Ohio
Laboratory
Collaborative
2012
Ohio
Clinical
Laboratory
Collaborative
2013
OhioClinical
Clinical
Laboratory
Collaborative
20132012
Organizations
Sponsoring
Sponsoring
Organizations
Sponsoring Organizations
American
Association
of Clinical
Chemistry
(AACC)
American
Association
of Clinical
Chemistry
(AACC)
American
Association
of Clinical
Chemistry
(AACC)
North Eastern
Ohio
AACC
North
Eastern
Ohio
AACCLeadership
Leadership
North
Eastern
Ohio Leadership
AACC
Eugenio Zabaleta,
PhD,
Chair
Eugenio
Zabaleta,
PhD, PhD,
ChairChair
Eugenio
Zabaleta,
MedCentral
Health
System
MedCentral
HealthSystem
System
-MedCentral
Health
ChristineChristine
Schmotzer,
MD, Chair
Elect
Christine
Schmotzer,
MD,
Chair
Elect
Schmotzer,
MD,
Chair
Elect
UH-UH
Case
Medical
Center
UH Medical
Case Medical
Center
Case
Center
Sihe
Wang,
PhD,Delegate
Delegate
Lisa
Kubit,
Past
Chair,
Lisa Kubit,
Past
Chair,
Program
ChairProgram
Sihe Wang,
PhD,
Delegate
Lisa
Kubit,
Past
Chair,
Program
ChairChair
Sihe
Wang,
PhD,
-Cleveland
ClinicClinic
-Cleveland
HeartLab,
Inc.
Cleveland
HeartLab,
Inc.
Cleveland
Clinic
Cleveland
HeartLab,
Inc.
Cleveland
David Anderson, PhD, Treasurer
Dustin Bunch, Continuing
David Anderson,
PhD, Treasurer
David
Anderson,
PhD,
Treasurer
-Cleveland
State
University
Education/Website Coordinator
ClevelandCleveland
State University
State University
-Cleveland Clinic
Anne Bordner Blank, Secretary
Dustin Bunch,
Continuing
Education/Website
Coordinator
Dustin
Bunch, Continuing
Education/Website
Coordinator
-Cleveland
Clinic
ClevelandCleveland
Clinic
Clinic
With nearly 10,000 members, AACC is the largest international society of
With nearly
10,000
AACC laboratory
is AACC
the largest
society ofsociety
research
With
nearlymembers,
10,000
isprofessionals,
theinternational
largest international
of research
research
orientedmembers,
clinical
physicians,
research
oriented clinical
laboratory
professionals,
physicians,
research
scientists
and
others
oriented
clinical
professionals,
physicians,
research
scientists
and
others
scientists
andlaboratory
others
in the
field
of clinical
laboratory
medicine.
Founded
in 1948,
in the field
of
clinical
laboratory
medicine.
Founded
in
1948,
the
society
is
in the
the society
field ofis headquartered
clinical laboratory
medicine. DC.
Founded
1948, come
the society
in Washington,
AACC in
members
from a is
headquartered
in of
Washington,
DC.
AACC
members
come industry
from
a(26%)
variety
headquartered
in Washington,
DC.
AACC
come
from
a of
variety of
variety
employment
settings:
hospital
labsmembers
(50%),
and
employment
settings: settings:
hospital
labs 30%
(50%),
industry
(26%) is
and
independent
employment
hospital
labs
(50%),
industry
(26%)
and independent
independent
labs (24%).
of the
membership
international.
23 labs
local arealabs
(24%). 30%
of the
membership
is international.
area
sections
and 13 and 13
(24%).
30%and
of 13
thespecialty
membership
is international.
23
local
area sections
sections
divisions
focus23
onlocal
laboratory
medicine
subspecialties
specialty specialty
divisions
focus
onfocus
laboratory
medicine
subspecialties
such asDiagnostics,
Point as
of Point
on laboratory
medicine
subspecialties
such
such asdivisions
Point of
Care,
Pediatric
Maternal
Fetal, and
Molecular
to of
Care, Pediatric
Maternal
Fetal, andFetal,
Molecular
Diagnostics,
to name atofew.
Care,
Pediatric
and Molecular
Diagnostics,
name a few.
name
a few. Maternal
AACC’s annual
meeting
and
exposition
isexposition
often held
with
ASCLS
and
is theandand
AACC’s
annual
meeting
andand
exposition
is often
held
jointly
withwith
ASCLS
is the
AACC’s
annual
meeting
isjointly
often
held
jointly
ASCLS
is
largest inlargest
thethe
field
medicine
attracting
nearlyattracting
20,000
andparticipants
in of
thelaboratory
field
of field
laboratory
medicine
attracting
nearlyparticipants
20,000
participants
and
largest
in the
of laboratory
medicine
nearly 20,000
600 exhibitors.
AACC
is AACC
a majorisAACC
publisher
of
books
and
fiveofmajor
periodicals
on
600and
exhibitors.
a major
of
books
and
five
major
on
600 exhibitors.
is apublisher
major
publisher
books
and
fiveperiodicals
major
clinical laboratory
science.
Clinical
Chemistry
is an international
peer reviewed
clinical
laboratory
science.
Clinical Chemistry
is an international
reviewed
periodicals
on clinical
laboratory
science.
Clinical
Chemistry
ispeer
an international
journal and
is
theand
most
cited
journal
injournal
the
field.
Clinical
Laboratory
offers
journal
is the
most
cited
in the
field.journal
Clinical
News offers
peer
reviewed
journal
and
is the
most
cited
in Laboratory
theNews
field. Clinical
breaking breaking
news
stories
feature
and
viewpoints
from
newswith
stories
witharticles
feature
articles
and
viewpoints
fromclinical
leading and
clinical
Laboratory
News
offers
breaking
news
stories
withleading
feature
articles
laboratorylaboratory
scientists.
Clinical
Laboratory
Strategies
addresses
the
essentials
of
scientists.
Clinical
Laboratory
Strategies
addresses
the
essentials
viewpoints from leading clinical laboratory scientists. Clinical Laboratory of
laboratorylaboratory
management
and mastering
change inchange
laboratory
practice.
In addition
to
management
and
in laboratory
practice.
Inmastering
addition to
Strategies
addresses
themastering
essentials
of
laboratory
management
and
the AACCthe
member
a
joint
venture
ASCLS,
Lab
TestsLab
Online
AACC website,
member
website,
a jointInwith
venture
with
ASCLS,
Testswebsite,
Online a joint
change
in laboratory
practice.
addition
to the
AACC
member
(www.labtestsonline.org)
has won
several
awards
and
hostsand
more
than
700,000
(www.labtestsonline.org)
wonOnline
several
awards
hosts
more
than
venture with ASCLS,
Labhas
Tests
(www.labtestsonline.org)
has 700,000
won
visitors per
month.
information
on AACC
visit
www.aacc.org.
visitors
perFor
month.
For information
AACC
visit visitors
www.aacc.org.
several
awards
and
hosts
more on
than
700,000
per month. For information
on AACC visit www.aacc.org.
Northeast Ohio AACC Leadership can be found at:
http://www.aacc.org/members/committees/local_section/Pages/LSNEO.aspx
15
2013
Ohio Clinical
Laboratory
Collaborative
Ohio Clinical
Laboratory
Collaborative
2012 2012
Sponsoring
Organizations
Sponsoring
Organizations
American Society for Clinical Laboratory Science – Ohio (ASCLS-Ohio)
American
Association
of Clinical
Chemistry
(AACC)
American
Association
of Clinical
Chemistry
(AACC)
North Eastern
Ohio Leadership
AACC Leadership
North Eastern
Ohio AACC
Eugenio Zabaleta,
PhD, Chair
Eugenio Zabaleta,
PhD, Chair
MedCentral
Health
System
ASCLSOhio
Leadership
MedCentral
Health
System
Schmotzer,
MD,
Chair Elect
ChristineChristine
Schmotzer,
MD, Chair
Elect
UH CaseCenter
Medical Center
UH Case Medical
Stacy Baker, Interim President
Melanie Giusti, Senior Director
Lisa
Kubit,
Past
Chair, Program Chair Sihe Wang,
Sihe
Wang,
PhD, Delegate
Lisa Kubit,
Past
Chair,
Program
PhD,
Delegate
-Galloway,
Ohio Chair
-Florence,
Kentucky
Cleveland
HeartLab,
Inc.
Cleveland
Clinic
Cleveland
HeartLab,
Inc.
Cleveland
Clinic
Shannon Kern, Recording Secretary Greg Attenweiler, Senior Director
-Proctorville, Ohio
-Dayton, Ohio
David Anderson,
PhD, Treasurer
David Anderson,
PhD,
Treasurer
Catherine Shaffner, Treasurer
Sheila Ng, Junior Director
Cleveland
State University
Cleveland
State University
-Perrysburg,
Ohio
-Toledo, Ohio
Laura Hook, Senior Director
Linda Graeter, Junior Director
DustinContinuing
Bunch, Continuing
Education/Website
Coordinator
Dustin Bunch,
Education/Website
Coordinator
-Canal Winchester, Ohio
-Waynesville, Ohio
ClevelandCleveland
Clinic Clinic
With10,000
nearlymembers,
10,000 members,
AACC
is theinternational
largest international
of research
With nearly
largest
society
ofsociety
research
Founded
in 1933,AACC
ASCLSisisthe
made
up of and governed
by practitioners
in clinical
clinical laboratory
professionals,
physicians,
research
scientists
and others
oriented oriented
clinical
laboratory
professionals,
physicians,
research
scientists
and
others
laboratory science. ASCLS-OH’s mission is to promote the profession of clinical
in the
of laboratory
clinical laboratory
medicine.
Founded
inthe
1948,
the is
society is
in the field
of field
clinical
medicine.
Founded
in 1948,
society
laboratory
science in Ohio
and provide
beneficial
services
to those
who practice
headquartered
in Washington,
DC. members
AACC members
comea from
a of
variety of
headquartered
in
Washington,
DC.
AACC
come
from
variety
it.
employment
settings:
hospital
labs
(50%),
industry
(26%)
and
independent
labs
employment settings: hospital labs (50%), industry (26%) and independent labs
(24%).
of the membership
is international.
local
area sections
(24%). 30%
of 30%
the membership
is international.
23 local 23
area
sections
and 13 and 13
specialty
divisions
focus
on
laboratory
medicine
subspecialties
such
as
specialty divisions
focus
on on
laboratory
medicine
subspecialties
as Point
of Point of
Besides
serving
the board
of directors,
committeessuch
or scientific
assemblies
for
Care,ASCLS-OH,
Pediatric
Fetal,
tofew.
name
a few.
Care, Pediatric
MaternalMaternal
Fetal,
and
Molecular
Diagnostics,
to name
a
members
mayand
alsoMolecular
choose
toDiagnostics,
work
with ASCLS
national
committees.
ASCLS
publishes
a bimonthly
journal,
Clinical
Laboratory
AACC’s
annual and
meeting
and
exposition
is often
held
jointly
withand
ASCLS
AACC’s annual
meeting
exposition
is often
held
jointly
with
ASCLS
is theand is the
along
a monthly
national
newsletter,
ASCLS
in of
thelaboratory
field
of with
laboratory
medicine
attracting
nearly
20,000Today.
participants
and
largest inlargest
the Science,
field
medicine
attracting
nearly
20,000
participants
andASCLS-OH
publishes
a
newsletter,
Ohio
CLS
Today.
600 exhibitors.
a major publisher
books
and five
major periodicals
on
600 exhibitors.
AACC is AACC
a majorispublisher
of books of
and
five major
periodicals
on
clinical laboratory
Clinical Chemistry
is an international
peer reviewed
clinical laboratory
science. science.
Clinical Chemistry
is an international
peer reviewed
journal
is the
most
citedinjournal
in the
field. Laboratory
Clinical Laboratory
News offers
journal and
is theand
most
cited
journal
the field.
Clinical
News offers
laboratorians
are
toand
be viewpoints
members
offrom
ASCLS
e.g.clinical
clinical
newswith
stories
withinvited
feature
articles
and viewpoints
from
leading laboratory
clinical
breaking breaking
newsAllstories
feature
articles
leading
scientists,
clinical
laboratory
technicians,
histotechnologists,
histotechnicians,
laboratory
scientists.
Clinical
Laboratory
Strategies
addresses
the
essentials
of
laboratory scientists. Clinical Laboratory Strategies addresses the essentials of
generalists,
specialists,
managers/supervisors,
phlebotomists
and
others.
Please
laboratory
management
and mastering
in laboratory
In to
addition to
laboratory
management
and mastering
change inchange
laboratory
practice. practice.
In addition
join
us
at
the
ASCLS-OH
Membership
Booth
to
learn
more
about
ASCLS
and
the
AACC
member
website,
a
joint
venture
with
ASCLS,
Lab
Tests
Online
the AACC member website, a joint venture with ASCLS, Lab Tests Online
ASCLS-OH
or
visit
our
websiteswww.ascls.org
and
www.ascls-ohio.org.
(www.labtestsonline.org)
wonawards
severaland
awards
hosts
more
than 700,000
(www.labtestsonline.org)
has won has
several
hostsand
more
than
700,000
visitors
perFor
month.
For information
AACC
visit www.aacc.org.
visitors per
month.
information
on AACCon
visit
www.aacc.org.
All ASCLS members including students are encouraged to join the ASCLS-Ohio
leadership during the conference at the Board of Directors meeting (which will be
held on Wednesday May 8th at 7pm) and the .Member Business Meeting (which
will be held on Friday May 10th at 7:30am).
16
2013
Ohio Clinical
Laboratory
Collaborative
Ohio Clinical
Laboratory
Collaborative
2012 2012
Sponsoring
Organizations
Sponsoring
Organizations
Clinical Laboratory Management Association (CLMA)
American
Association
of Clinical
Chemistry
(AACC)
American
Association
of Clinical
Chemistry
(AACC)
North Eastern
Ohio Leadership
AACC Leadership
North Eastern
Ohio AACC
FirstZabaleta,
OhioChair
Chapter
Leadership ChristineChristine
Eugenio
PhD, Chair
Schmotzer,
MD,
Chair Elect
Eugenio Zabaleta,
PhD,
Schmotzer,
MD, Chair
Elect
MedCentral
Health System
UH CaseCenter
Medical Center
MedCentral
Health System
Case Medical
BoardUH
of Directors:
Allen Nickels, President
Louise Headley, Past President
Lisa
Kubit,
Past
Chair,Treasurer
Program
Lisa Kubit,
Past
Chair,
Program
Chair Chair
Katherine
Jacob,
Cleveland
HeartLab,
Inc.
Cleveland
HeartLab,
Inc.
Rosanne Kelley, Secretary
David Anderson,
PhD, Treasurer
David Anderson,
PhD, Treasurer
Six
Rivers
Chapter
Leadership
Cleveland
State University
Cleveland
State
University
Sihe
Wang,
PhD, Delegate
Sihe
PhD,
Delegate
Pat Wang,
Webster
Cleveland
Clinic
Cleveland
Clinic
Jean Komraus
Clive Hamlin
Ed Lorson
Jane Tester, President
Board of Directors:
Lena Alvis, Secretary
Jennifer Douglas
Emily
Adams,
President-Elect
Mary Coordinator
Beth Kasper
Dustin
Bunch,
Continuing
Education/Website
Dustin Bunch,
Continuing
Education/Website
Coordinator
Kathy
Good,
Past
President
Richard
Kuertz
ClevelandCleveland
Clinic Clinic
With10,000
nearlymembers,
10,000 members,
isJenny
theinternational
largest
international
of research
With nearly
AACC
is AACC
the largest
society ofsociety
research
Wanda
Broerman,
Treasurer
Murray
clinical laboratory
professionals,
physicians,
and others
oriented oriented
clinical laboratory
professionals,
physicians,
researchresearch
scientistsscientists
and others
in the
of laboratory
clinical laboratory
1948,
the is
society is
in the field
of field
clinical
medicine.medicine.
FoundedFounded
in 1948,inthe
society
Western Lake Erie Chapter Leadership
headquartered
in Washington,
DC. members
AACC members
comea from
variety of
headquartered
in Washington,
DC. AACC
come from
varietya of
employment
settings:
hospital
labs
(50%),
industry
(26%)
and
independent
labs
employment settings:
hospital
labs (50%), industry
and independent labs
Board(26%)
of Directors:
Pamela Kin,
President
(24%).
of the
membership
is international.
23
local
area sections
(24%). 30%
of 30%
the
membership
is international.
23 local
area
sections
and 13 and 13
Tom
Bierley,
President-Elect
Rhonda
Perry,
Past
President
divisions
focus
on
laboratory
medicine
subspecialties
such
as
specialty specialty
divisions
focus
on
laboratory
medicine
subspecialties
such
as
Point
of Point of
Mary Slaughter, Secretary
Brad Stotz
Care,Joan
Pediatric
Maternal
Fetal,
and Molecular
tofew.
name a few.
Benya,
Treasurer
Karen Diagnostics,
Bodeman
Care, Pediatric
Maternal
Fetal,
and
Molecular
Diagnostics,
to name a
Bonnie Van Schoik
AACC’smeeting
annual and
meeting
and exposition
is often
held
jointly
withand
ASCLS
AACC’s annual
exposition
is often held
jointly
with
ASCLS
is theand is the
is
an international
organization
whose20,000
membership
is responsible
for
in of
the
field
of laboratory
medicine
nearlyparticipants
20,000
participants
and
largest inlargest
the CLMA
field
laboratory
medicine
attractingattracting
nearly
and
laboratories
and
clinical
services
in
hospitals,
healthcare
networks,
group
600 exhibitors.
a major publisher
books
and five
major periodicals
on
600 exhibitors.
AACC is AACC
a majorispublisher
of books of
and
five major
periodicals
on
practices
andscience.
independent
settings.
Theinternational
First
Ohio,
Six
andreviewed
Western Lake
clinical
laboratory
Clinical
Chemistry
is an
international
peer
clinical laboratory
science.
Clinical
Chemistry
is an
peerRivers
reviewed
Chapters
ofjournal
CLMA
organizations
dedicated
to excellence
journal
is the
most
citedinare
journal
in the
field.
Clinical Laboratory
News
offers in
journal and
is Erie
theand
most
cited
theprofessional
field.
Clinical
Laboratory
News offers
services;
towith
enhancing
professional,
managerial
and
leadership
skills; to
news
stories
featureand
articles
and viewpoints
from
leading
clinical
breaking breaking
newsclinical
stories
with
feature
articles
viewpoints
from leading
clinical
promoting
efficient,
productive
and
high
quality
operations;
advocating
on
behalf
laboratory
scientists.
Clinical
Laboratory
Strategies
addresses
the
essentials
of
laboratory scientists. Clinical Laboratory Strategies addresses the essentials of
of
quality
patient
care
and
chapter
membership.
laboratory
management
and mastering
in laboratory
In to
addition to
laboratory
management
and mastering
change inchange
laboratory
practice. practice.
In addition
the
AACC
member
website,
a
joint
venture
with
ASCLS,
Lab
Tests
Online
the AACC
member
website,
a
joint
venture
with
ASCLS,
Lab
Tests
Online
These Chapters provide education, regulatory information and networking
(www.labtestsonline.org)
has
wone-mails
severalwith
awards
and
hosts
more
than 700,000
(www.labtestsonline.org)
won
several
awards
and
hosts
more
than
700,000
opportunities. has
CLMA
provides
the
latest
regulatory
updates
and
visitors
per
month.
For
information
on
AACC
visit
www.aacc.org.
visitors per
month.
For
information
on
AACC
visit
www.aacc.org.
industry trends as well as newsletters and journals to its members.
This organization is an invaluable asset for current and future laboratory leaders.
First Ohio-CLMA Leadership can be found at http://www.clma.org/group/FOC
Western Lake Erie-CLMA Leadership found at http://www.clma.org/group/WLEC
Six Rivers-CLMA Leadership can be found at http://www.clma.org/group/SRC
17


Register Early
Online registration.
Visit our website at:
Register
Early
http://www.cvent.com/d/3cqcvr
Online registration. Visit our website at:
If you are planning to attend the conference,
http://www.cvent.com/d/3cqcvr
you are strongly encouraged to register
If you are planning to attend
the conference,
before
the April
26th postmark
deadline in
you
are strongly
encouraged
to register
th
order
to
take
advantage
of
the
lower
before the April 26 postmark deadlineearly
in
registration
fees. After
26th,early
all
order
to take advantage
of April
the lower
registrants
mustAfter
payApril
the regular/onsite
fees.
registration
fees.
26th, all
Please
see
the
complete
instructions
for
registrants must pay the regular/onsite fees.
registration
the registration
Please
see theadjacent
completetoinstructions
for form for
more information.
registration
adjacent to the registration form for
more information.
Conference Registration Areas Hours
Conference Registration Areas Hours
On-site registration and registration check-in
On-site
registration
will beregistration
held at theand
Crowne
Plaza check-in
Columbus
willNorth
be held
at
the
Crowne
Plaza
Columbus
during the following days and times:
North during the following days and times:
Wednesday, May 8
12:30 pm – 5:00 pm
Wednesday, May 8
12:30 pm – 5:00 pm
Thursday, May 9
8:00 am – 5:30 pm
Thursday, May 9
8:00 am – 5:30 pm
Friday, May 10
7:30 am – 3:30 pm
Friday, May 10
7:30 am – 3:30 pm
Continental Breakfast
Continental Breakfast
Plan to join your colleagues at the
Plan to join your colleagues at the
complimentary
Continental
Breakfast
complimentary
Continental
Breakfast
on on
Thursday
and
Friday
mornings
from
Thursday and Friday mornings from 8:008:00
am- am8:30
am.
8:30 am.
Name Badges
Name
Badges
A name
badge must be worn by all conference
attendees for admission to all sessions, the
A name badge must be worn by all conference
Student Academic Challenge, and all breaks
attendees for admission to all sessions, the
and food/social functions.
Student Academic Challenge, and all breaks
and food/social functions.
Documentation of Continuing Education
Documentation of Continuing Education
ASCLS-Ohio is an approved provider of
continuing
education
programs
ASCLS-Ohio
is an
approved
provider by
of the
American
Society
for Clinical
Laboratory
continuing
education
programs
by the
®
Science
(ASCLS)
P.A.C.E.
Program. This
American
Society
for Clinical
Laboratory
®
conference
a wide
range ofThis
educational
Science
(ASCLS)offers
P.A.C.E.
Program.
opportunities
meet
yourofcontinuing
conference
offers atowide
range
educational
opportunities
to requirements.
meet your continuing
education
A “Certificate of
education
requirements.
A “Certificate
of sessions
Attendance”
will be validated
for all
Attendance”
will
be
validated
for
all
sessions
attended.
attended.
Dietary/Special Accommodations
Dietary/Special Accommodations
If you have special needs that require
If youaccommodation
have special needs
that require
(including
dietary allergies and
accommodation (including dietary allergies and
vegetarian), contact Laura Hook at
vegetarian), contact Laura Hook at
mlt_laura@yahoo.com to make appropriate
mlt_laura@yahoo.com to make appropriate
arrangements. Forty-eight (48) hour advanced
arrangements. Forty-eight (48) hour advanced
noticed
is needed
tomost
fulfill requests.
most requests.
noticed
is needed
to fulfill

SAVE
THE
DATE!
SAVE
THE
DATE!
OHIO
2014
COLLABORATIVE
LABORATORY
CONFERENCE
OHIO
2014
COLLABORATIVE
LABORATORY
CONFERENCE
th th th th
May
7 7– 9– 9
May
Columbus,
OHOH
Columbus,
18

Join Us for a Greet, Eat and Meet Night
Wednesday, May 8 5:00pm – 7:00pm
The Ohio 2013 Collaborative Laboratory Conference steering committee, co-chairs, and all
members invite you to a social event to kick off this special conference. The Wednesday night
dinner will be included with all full registrations. This is an opportunity to catch up with friends
and colleagues, make new ones, and relax before the conference swings into full gear on
Thursday. Please make certain to check the Wednesday dinner on your registration so
that we may plan for your meal.
Vendor Exhibits and Reception
Thursday, May 9 Exhibits starting at 12:00pm. Reception- 5:00 pm – 7:00 pm
Friday, May 10 Exhibits 9:30 am – 1:30 pm
Social Event- Fun at the Lanes
Thursday, May 9 8:00pm
Join us Thursday after the vendor reception for our social event outside of the CLC conference.
We will be going to the Columbus Square Bowling Palace at 8:00 pm for a night of bowling.
Meet members of the sponsoring organizations and delve into the opportunities of the
profession while kicking back with some gutter balls and friendly banter. The cost will be
approximately $3.50/person/game. This price includes shoe rental.
Student Academic Challenge
Friday, May 10 2:30 – 5:00 p.m.
The ASCLS Academic Challenge committee is looking for excited, enthusiastic MLT/MLS
students to join in participating in the 10th annual Academic Challenge. (AKA: Student Bowl).
To organize your team you will need three members and one or two alternates. Team members
must be registered participants for the meeting in order to qualify being on a team.
As last year’s winner, Southwest General will be defending their title at the competition this year.
The deadline for registering your team is rapidly approaching, so get your team organized, and
come join students from all around the state for an afternoon of educational FUN!
Charity Opportunity – Canned Food Drive
All days at Registration area
Mid-Ohio Food Bank- non-perishable food and monetary donations will be accepted on-site or
visit the link below and select the CLC 2013 button:
http://fooddrive.midohiofoodbank.org/site/TR/FundraisingEvent/General?px=1044441&pg=personal&fr_id
=1140
19
outside with some of the latest Chemistry, Hematology
andwith
Immunoassay
outside
some of theinstruments.
latest Chemistry, Hematolo
The exhibit hall will give you the opportunity to talk The
to numerous
representatives
from
exhibit hall will give you the
opportunity to talk t
the different companies, so you can compare the pros
and conscompanies,
of different so
systems,
the different
you canallcompare the pr
at the same time.
at the same time.




Each year these vendors help sponsor the Clinical Each
Laboratory
Conference.
play a the Clinical L
year these
vendors They
help sponsor
significant role in sponsoring speakers, breaks, andsignificant
lunches, role
helping
to make it possible
in sponsoring
speakers, breaks, and
for us to put on the caliber of conference we do each
year.
Please
take
time during
the
for us to put on the caliber
of conference
we do eac
conference
to
visit
with
them,
learn
about
new
laboratory
products,
make
great
to visit
with them,
learn about new labor
The Collaborative Laboratory Conference for 2013conference
will have many
vendors
present
connections
and
thank
them
for
their
support.
connections
and
thank
them
for
again,
to show us Laboratory
what’s new Conference
in our field. for
There
willwill
behave
demonstration
vanspresent
parkedtheir support.
The
Collaborative
2013
many vendors
outsidetowith
some
of the latest
Hematology
Immunoassay
again,
show
us what’s
new inChemistry,
our field. There
will be and
demonstration
vansinstruments.
parked
Vendors
that
we
will
be
seeing
include:
The
exhibit
hall
will
give
you
the
opportunity
to
talk
to
numerous
representatives
outside with some of the latest Chemistry, Hematology
and Immunoassay
Vendors
that we will be instruments.
seeingfrom
include:
the different
companies,
so you
comparetothe
and cons representatives
of different systems,
The
exhibit hall
will give you
the can
opportunity
talkpros
to numerous
from all
at the
same
time.
the
so you can compare the pros and cons of different systems, all
•different
ARUPcompanies,
Laboratories
• ARUP Laboratories
at the same time.
• Beckman Coulter
• Beckman
Coulter They play a
Each year these vendors help sponsor the Clinical Laboratory
Conference.
• year
BD these
significant
role invendors
sponsoring
breaks,
andLaboratory
lunches,
to make
it possible
Each
helpspeakers,
sponsor the
Clinical
Conference.
They
play a
• BD helping
for
us
to
put
on
the
caliber
of
conference
we
do
each
year.
Please
take
time
during
the
significant
role in sponsoring
speakers, breaks, and lunches, helping to make it possible
• Instrumentation
Laboratories
•
Instrumentation
Laboratories
conference
them,
learn aboutwe
new
maketime
great
for
us to putto
onvisit
the with
caliber
of conference
dolaboratory
each year.products,
Please take
during the
• LabCorp
connections
their
support.
conference
toand
visitthank
with them
them,for
learn
about
new laboratory
products,
make
great
• LabCorp
connections
and
thank
them
for
their
support.
• M.S. Stegall & Associates
• M.S. Stegall & Associates
Vendors that we will be seeing include:
• Ortho-Clinical Diagnostics Inc.
• Ortho-Clinical Diagnostics Inc.
Vendors that we will be seeing include:
•• Roche
ARUP Laboratories
• Roche
•• ARUP
Laboratories
RROS
iScrHoc
Healthcare
Beckman
Coulter
• RROS iScrHoc Healthcare
•• Beckman
Coulter
Siemens
Diagnostics
BD
•• BD
Siemens
Water Laboratories
Instrumentation
•• Instrumentation
Laboratories
Sysmex
LabCorp
•
Siemens Diagnostics
•
Siemens Water
•
Sysmex
•• LabCorp
W.E.L.
Instrument
Company
M.S. Stegall
& Associates
• W.E.L. Instrument Company
•• M.S.
Stegall
& Diagnostics
Associates Inc.
And
many
others
Ortho-Clinical
• And many others
The
sponsoring organizations would
•• Ortho-Clinical
Diagnostics Inc.
Roche
like
to thank
you for
your
support.
We are looking forward to our annual Vendor Reception,
weforward
can
have
a cocktail
We arewhere
looking
to our
annual Vendor Recep
•
Roche
Welcome
to the 2012 Collaborative
RROS iScrHoc
Healthcare
and•appetizers
with them
and be able to do some serious
networking.
and appetizers with them and be able to do some se
Laboratory Conference!
•• RROS
iScrHoc
Healthcare
Siemens Diagnostics
•• Siemens
Siemens Diagnostics
Water
The sponsoring organizations would
•• Siemens
Water
like to thank you for your support.
Sysmex
Welcome to the 2012 Collaborative
•• Sysmex
W.E.L. Instrument Company
The sponsoring organizations would
Laboratory Conference!
like
to
thank
you for your support.
•• W.E.L.
Instrument
Company
And many others
• And
many
others
The
sponsoring
organizations
would
Welcome
to
the 2012
2013 Collaborative
to thankforward
you for to
your
We like
are looking
oursupport.
annual Vendor Reception, where we can have a cocktail
to with
the 2012
andWelcome
appetizers
them
and
be ableVendor
to do Conference!
some
seriouswhere
networking.
Laboratory
We
are
looking
forward
toCollaborative
our annual
Reception,
we can have a cocktail
Laboratory
Conference!
and appetizers
with them
and be able to do some serious networking.
20

Ohio CLC 2013: An Exploration of Medical Laboratory Science
Guest rooms have been reserved at the Crowne Plaza for the nights of Tuesday May 7th to
Thursday, May 9th with a special rate of $89.00 per night, plus applicable taxes (king bed or
double beds) for conference attendees. These group rates are available until April 26th or
they run out of rooms so be sure and book early!
To book a room at the Crowne Plaza - call the Crowne Plaza at 1-614-885-1885. State when
making your reservation that you are attending the Ohio Collaborative Laboratory Conference
(CLC) and note that the group code is LAB
CBL (group code must be used when making
reservations).
Crowne Plaza, Columbus North
6500 Doubletree Ave
Columbus, Ohio 43229
(614) 885-1885
FROM CLEVELAND AND POINTS NORTH EAST:
I-71 South to Exit 117. Take the right and follow signs for OH-161.Turn right
onto OH-710 North/ Busch Blvd. Turn right onto Kingsmill Pkway. Arrive at
6500 Doubletree Ave.
FROM CINCINNATI:
Take I-71 North toward Columbus. Take the ramp right for I-70 East/ I-71
North toward Cleveland. At Exit 101A take ramp left for I-71 North to
Cleveland. At exit 117 take ramp right and follow signs for OH-161.Turn left
ontoOH-161W/E Dublin Granville Rd. Turn right onto OH-710 North/ Busch
Blvd. Turn right onto Kingsmill Pkway. Arrive at 6500 Doubletree Ave.
FROM THE WEST:
Take I-70 East toward Columbus. Keep left onto I-670 East. At exit 5B take
ramp left for I-71 North toward Cleveland. Keep left onto I-71 South. At exit
117 take the right and follow signs for OH-161.Turn left onto OH-161W/E
Dublin Granville Rd.Turn right onto OH-710 North/ Busch Blvd. Turn right
onto Kingsmill Pkway. Arrive at 6500 Doubletree Ave.
21


General
GeneralRegistration
Registration
On-line
On-lineregistration
registrationand
andcredit
creditcard
cardpayment.
payment.Check
Checkout
outthe
thewebsite
websiteatathttp://www.cvent.com/d/3cqcvr.
http://www.cvent.com/d/3cqcvr.
The
Theconference
conferenceregistration
registrationfee
feeincludes
includesadmission
admissiontotoscientific
scientificsessions,
sessions,refreshment
refreshmentbreaks,
breaks,lunch,
lunch,dinner
dinnerand
and
the
thevendor
vendorsponsor
sponsortables.
tables.Lunch
Lunchrequires
requiresa aticket
ticketthat
thatwill
willbe
beprovided
providedininyour
youronsite
onsiteregistration
registrationpacket.
packet.Dinner
Dinner
Wednesday
Wednesdaynight
nightwill
willalso
alsobe
beincluded
includedwith
witha afull
fullregistration
registrationororWednesday
Wednesdayonly
onlyregistration.
registration.Please
Pleasebe
besure
suretoto
mark
markwhether
whetherorornot
notyou
youplan
plantotoattend
attendon
onyour
yourregistration
registrationform.
form.It Itisisvery
veryimportant
importanttotonote
noteon
onthe
theregistration
registration
form
formwhat
whatsessions
sessionsyou
youexpect
expecttotobe
beattending
attendingtotoensure
ensureadequate
adequateseating.
seating.Do
Donot
notselect
selectmore
morethan
thanone
one
session
sessionscheduled
scheduledatatthe
thesame
sametime.
time.Some
Somesessions
sessionswill
willbe
belimited
limitedtotoa amaximum
maximumseating
seatingofof30
30people.
people.
Dietary
Dietary/Special
/SpecialAccommodations
Accommodations
If Ifyou
youhave
haveany
anydietary
dietaryrestrictions
restrictionsororvegetarian
vegetarianneeds,
needs,please
pleasecontact
contactLaura
LauraHook
Hookatatmlt_laura@yahoo.com
mlt_laura@yahoo.com
prior
priortotothe
theconference
conferencetotoensure
ensureadequate
adequatetime
timefor
fora alunch
lunchtotobe
beprepared.
prepared.
Attention:
Attention:Members
Membersof
ofAACC,
AACC,ASCLS,
ASCLS,CLMA
CLMA
When
Whencompleting
completingthe
theconference
conferenceregistration
registrationform,
form,please
pleasecheck
checkthe
theappropriate
appropriatemember
memberbox(es)
box(es)– –and
andprovide
provide
your
yourmember
membernumber
numberfor
foreach.
each.This
Thiswill
willensure
ensurethat
thatyour
yourstatus
statusasasa amember
memberofofone
one(or
(ormore)
more)ofofthe
the
collaboration
collaborationorganizations
organizations(AACC
(AACC– –Northeast
NortheastOhio
OhioSection,
Section,ASCLS-Ohio,
ASCLS-Ohio,CLMA–First
CLMA–FirstOhio,
Ohio,Six
SixRivers
Riversoror
Western
WesternLake
LakeErie
ErieChapter)
Chapter)isisrecognized
recognizedand
andmember
memberregistration
registrationfees
feeswill
willapply.
apply.Your
Yourcurrent
currentmembership
membership
status
statusininthe
theorganization(s)
organization(s)selected
selectedwill
willbe
beverified.
verified.
Institutional
InstitutionalRegistration
Registration
Badges
Badgesmay
maybe
bepurchased
purchasedtotoenable
enableseveral
severalemployees
employeesfrom
froman
aninstitution
institutiontotoattend
attendselected
selectedsessions
sessionsduring
during
the
theconference
conferencewithout
withouteach
eachperson
personneeding
needingtotoregister
registerfor
fora asingle
singleday.
day.
The
Theprice
priceofofthe
theinstitutional
institutionalbadges
badgesisis$250
$250for
forthe
thefirst
firstbadge
badgeand
and$175
$175for
foreach
eachadditional
additionalbadge
badgepurchased
purchasedbyby
the
theearly
earlyregistration
registrationdeadline.
deadline.The
Thebadges
badgesmay
maybe
betransferred
transferredasasdesired
desiredtotoallow
allowmaximum
maximumparticipation.
participation.One
One
lunch
lunchticket
ticketwill
willbe
beprovided
providedon
onThursday
Thursdayand
andFriday
Fridayfor
foreach
eachbadge
badgepurchased.
purchased.
Please
Pleaseprovide
providethe
thename
nameofofa acontact
contactindividual
individualfor
forany
anyquestions
questionsconcerning
concerningthe
theinstitutional
institutionalregistration
registrationand
andtoto
obtain
obtaina alisting
listingofofthose
thoseindividuals
individualswho
whowill
willbe
beusing
usingthe
thebadges
badgesand
andthe
thesessions
sessionsthey
theywill
willbe
beattending.
attending.To
To
assist
assistwith
withthe
thescheduling
schedulingofofstaff
staffwho
whowill
willbe
beattending
attendingthe
theconference
conference(and
(andtotosubmit
submitwith
withthe
theregistration
registrationform
form
rkelley@ccf.orgtotorequest
requestan
anelectronic
electroniccopy
copyofofthe
the
ororvia
viaemail),
email),please
pleasecontact
contactRosanne
RosanneKelley
Kelleyatatrkelley@ccf.org
“Institutional
“InstitutionalBadge
BadgeUsers
UsersSession
SessionSelection
SelectionWorksheet”.
Worksheet”.
Sorry,
Sorry,no
noon-site
on-siteregistration
registrationisisavailable
availablefor
forinstitutional
institutionalbadges.
badges.
Early
EarlyRegistration
Registration
Early
Earlyregistration
registrationMUST
MUSTbe
beentered
enteredon-line
on-lineororif ifmailed,
mailed,postmarked
postmarkedon
onororbefore
beforeApril
April26,
26,2013.
2013.After
Afterthis
thisdate,
date,
the
thehigher
higheron-site
on-sitefees
feesapply.
apply.
Refund/
Refund/Cancellation
Cancellation Policies
Policies
Full
Fullregistration
registrationfees
feeswill
willbe
berefunded
refundedonly
onlyif ifa awritten
writtenrequest
requestisispostmarked
postmarkedon
onororbefore
beforeApril
April26,
26,2013.
2013.AA
session
sessionmay
maybe
becancelled
cancelledif ifthere
thereisisinsufficient
insufficientinterest
interestfrom
fromregistrants.
registrants.
Questions
Questions/ /Need
NeedMore
MoreInformation?
Information?
Melanie
MelanieGiusti,
Giusti,Co-Chair:
Co-Chair:melanie.giusti@uc.edu
melanie.giusti@uc.edu
Allen
AllenNickels:
Nickels:nickelsa@summahealth.org
nickelsa@summahealth.org
Dustin
DustinBunch,
Bunch,Co-Chair:
Co-Chair:bunchd@ccf.org
bunchd@ccf.org
Stacy
StacyBaker:
Baker:stacylacy2@columbus.rr.com
stacylacy2@columbus.rr.com
Catherine
JaneTester:
Tester:jane.l.tester@questdiagnostics.com
jane.l.tester@questdiagnostics.com
CatherineShaffner:
Shaffner:catherine.shaffner@promedica.org
catherine.shaffner@promedica.org Jane
Pam
PamKin:
Kin:pamela_kin@mhsnr.org
pamela_kin@mhsnr.org
22
Eugenio
EugenioZabaleta:
Zabaleta:ezabaleta@medcentral.org
ezabaleta@medcentral.org
Registration Form


See
See our
our website
website for
for online
online registration
registration at:
at: http://www.cvent.com/d/3cqcvr
http://www.cvent.com/d/3cqcvr
Name
Name ________________________________________________
________________________________________________
MEMBERSHIP: Check all that apply (include member #
 

Institution
Institution _____________________________________________
_____________________________________________
AACC, NEO-Member
# _____________________
Registration Form
See our website for online registration at: http://www.cvent.com/d/3cqcvr
Mailing
Mailing Address
Address ________________________________________
________________________________________
Name ________________________________________________
City
City // State
State // Zip
Zip Code
Code ___________________________________
___________________________________
Institution _____________________________________________
Phone:
(Day)
_________________
(Evening)
Phone:
(Day)
_________________
(Evening) _________________
_________________
Mailing
Address
________________________________________
Email
_________________________________________
Email
_________________________________________
City Address:
/Address:
State / Zip
Code ___________________________________
Are
you
member
of
or
N
Y
Are
you aa(Day)
member
of AACC,
AACC, ASCLS,
ASCLS,
or CLMA
CLMA
N
Phone:
_________________
(Evening)
_________________
Are
Are
you
youAddress:
aa student?
student?
N
Y
N
Y
Email
_________________________________________
Are you a member of AACC, ASCLS, or CLMA
Are you a student?
Registration
Registration Fees:
Fees:
N
Y
N
Y
Postmark
Postmark by April 26
Full Registration
Registration (Wed,Thurs,Fri)
(Wed,Thurs,Fri)
Full
Registration Fees:
Member
Member
Postmark by April 26
AACC, NEO-Student
# _____________________
ASCLS-Ohio
# _____________________
MEMBERSHIP: Check all that apply (include member #
AACC, NEO-Member
# _____________________
AACC,Professional
NEO-Student
# #_____________________
_____________________
Student
ASCLS-Ohio
# #_____________________
_____________________
st
st
CLMA-1 Professional
Ohio
CLMA-WLE
Student
N/A
# _____________________
N/A
# _____________________
st
CLMA-1 Rivers
CLMA-Six
Ohio
N/A
N/A
CLMA-WLE
N/A
CLMA-Six Rivers
N/A
After April 26
After April 26
$170.00
$170.00
$220.00
$ __________
$245.00
$245.00
$295.00
$ __________
Student Member
Member
Student
$70.00
$70.00
$120.00
$ __________
Student Nonmember
Nonmember
Student
$100.00
$100.00
$150.00
$ __________
Institutional,
First Badge
Badge
Institutional,
First
Student Nonmember
$250.00
$250.00
$100.00
$300.00
$150.00
$ $__________
__________
$175.00
$225.00
$ __________
Full Registration (Wed,Thurs,Fri)
Nonmember
Nonmember
Member
$170.00
Nonmember
$220.00
$245.00
Student Member
$295.00
$70.00
Institutional,
Each
Additional
Badge
Institutional,
Badge
Institutional,Each
FirstAdditional
Badge
# Additional
Badges =Dinner
_______
Wednesday
Collaboration
Dinner
Wednesday
Collaboration
Please
let
us
know
if
you
plan
to attend
attend
Please
let
us
know
if
you
plan
to
Wednesday Collaboration Dinner
$ __________
$120.00
$175.00
$175.00
$250.00
AdditionalEach
Badges
_______
## Additional
Badges
== _______
Institutional,
Additional
Badge
$ __________
$ __________
$225.00
$300.00
YES,
YES, II will
will attend
YES, I will attend
Please let us
know if you plan to attend
Wednesday
Only
Wednesday
Only
Wednesday
Only
Member
$75.00
Member
$75.00
$ $__________
__________
NO, I will not attend
NO, I will not attend
$100.00
Wed. registration
$ __________
Member
Nonmember
Nonmember
$75.00
$105.00
$105.00
Student Member
Member
Student
$35.00
$35.00
$60.00
$ __________
Student Nonmember
Nonmember
Student
$45.00
$45.00
$70.00
$ __________
Member
Member
Member
$90.00
$90.00
$90.00
$130.00
$130.00
$ $__________
__________
Student
Member
Student
StudentMember
Member
$35.00
$35.00
$35.00
$60.00
$60.00
$ $__________
__________
Nonmember
$100.00
$130.00
Wed Dinner included in full or
Wed.
Wedregistration
Dinner included in full or
$105.00
Student Member
$130.00
$35.00
Student Nonmember
$60.00
$45.00
Thursday only
only 
 or
or Friday
Friday only
only 

Thursday
$70.00
__________
$ $__________
$ __________
$ __________
$ __________
Thursday only  or Friday only 
((Please
Please 
 day(s)
day(s) attending
attending –– fees
fees are
are each
each day)
day)
(Please  day(s) attending – fees are each day)
Nonmember
Nonmember
Nonmember
$125.00
$125.00
$125.00
Student
Nonmember
Student
StudentNonmember
Nonmember
$165.00
$165.00
$55.00
$55.00
$55.00
$80.00
$80.00
$ $__________
__________
$ $__________
__________
TOTAL $ $___________
___________
TOTAL
PleaseCIRCLE
CIRCLEthe
thesessions
sessionsyou
youplan
planto
attend:
Please
Please
CIRCLE
the
sessions
you
plan
totoattend:
Payment:by
bycheck
check
Payment:
Wednesday
Wednesday
Wednesday
W1 W2
W2 W3
W3 W4
W4 W5
W5 W6
W6 W7
W7 W8
W8 W9
W9
W1
W1
W2
W3
W4
W5
W6
W7
W8
W9
Thursday
Thursday
Thursday
T10
T11
T12
T13
T14
T15
T16
T17
T18
T19
T10
T10 T11
T11 T12
T12 T13
T13 T14
T14 T15
T15 T16
T16 T17
T17 T18
T18 T19
T19
Card: VISA
VISA
Master
Card Am
Am
Express
Card:
Master
Card
Express
Card
Number:
______________________________
Card Number: ______________________________
Expiration
Date:
_________________
Expiration
Date:
_________________
You can also register online at:
You can also register online at:
http://www.cvent.com/d/3cqcvr
T20
T20
T20
T21
T21
T21
T22
T22
T22
T23
T23
T23
T24
T24
T24
T25
T25
T25
T26
T26
T26
T27
T27
T27
T28
T28
T28
T29
T29
T29
Friday
Friday
Friday
F30
F31
F32
F33
F34
F35
F36
F37
F38
F39
F30
F30 F31
F31 F32
F32 F33
F33 F34
F34 F35
F35 F36
F36 F37
F37 F38
F38 F39
F39
F40
F41
F42
F43
F44
F45
F46
F47
ASCLS-Ohio
Member
F40
F40
F41
F41 F42
F42
F43
F43Meeting
F44
F44 (Friday)
F45
F45 F46
F46YesF47
F47
Academic Challenge
ASCLS-Ohio
ASCLS-Ohio
Member
Member Meeting
Meeting Yes
(Friday)
(Friday)
Yes
Yes
Academic
Academic Challenge
Challenge
Yes
Yes
F48
No
F48
F48
No
No
F49
F49
F49
creditcard
card
bybycredit
http://www.cvent.com/d/3cqcvr
Make Check payable to: ASCLS-Ohio – CLC 2013
Make Check payable to: ASCLS-Ohio – CLC 2013
Mail registration form and payment to:
Mail
registration
form2013
and payment to:
ASCLS-Ohio
– CLC
ASCLS-Ohio
– CLC
2013
c/o Catherine
Shaffner
c/o
Catherine
Shaffner
10204
N Shannon
Hills Ln
Perrysburg,
OhioHills
43551-2691
10204
N Shannon
Ln
Perrysburg, Ohio 43551-2691
23


April 25 – 27, 2012

2011 CLC Organization Logos
2011 CLC Organization Logos
Columbus, Ohio
Crowne Plaza North
PLEASE CIRCULATE
Tiffin. OH 44883
ASCLS Ohio 2009 Education Conference
ASCLS-Ohio
10204 N Shannon Hills Lane
Pam Kin
Perrysburg,
Ohio 43551
45 St. Lawrence
Dr.
bora2013
tivOhio
e Collaborative
LaborLaboratory
atorConference
y
ab
Conference
Ohio 2012
PRESORTED
FIRST CLASS
US POSTAGE PAID
TOLEDO OH
PERMIT 339



